rfhg_120740.1

Basic information about the TSS

---

TSS ID: rfhg_120740.1 Species: human Chr: chr9		Start: 133348297 End: 133348304 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4248403,EH38E2733916)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000426651.1:-45 ENST00000468019.5:-45 GeneID: 6130 HGNC/MGI_ID: HGNC:10364 UniProt_ID: Q5T8U3 Nearer transcript ids and distances:

Gene_name: RPL7A Gene_symbol: RPL7A Gene_synonyms: L7A SURF3 TRUP Gene_source: HGNC:10364

TATA-Box annotation

---

Distance to TSS:	82
Nearest PromoterID:	NM_000972
Entrez ID:	6130
Nearest Unigene:	Hs.499839
Nearest Refseq:	NM_000972
Nearest Ensembl:	ENSG00000148303
Gene Name:	RPL7A
Gene Alias:	L7A|SURF3|TRUP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.625000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL7A p2@RPL7A p3@RPL7A p4@RPL7A p5@RPL7A p7@RPL7A p8@RPL7A p9@RPL7A
Sample		p1@RPL7A	p2@RPL7A	p3@RPL7A	p4@RPL7A	p5@RPL7A	p7@RPL7A	p8@RPL7A	p9@RPL7A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	219.15	50.26	6.23	12.27	8.18	1.36	3.90	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	203.73	44.71	8.09	11.94	7.08	2.63	5.87	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	223.58	48.80	5.40	14.08	6.37	1.74	4.82	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	174.64	52.19	5.61	10.40	7.69	2.29	5.61	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	195.05	50.17	8.10	11.92	11.92	2.47	6.30	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	186.83	49.23	7.56	8.14	7.95	2.52	6.59	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	211.78	54.47	6.54	11.98	11.33	4.58	3.49	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	239.07	58.13	6.78	15.02	12.11	3.63	5.81	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	209.23	54.28	6.63	17.10	9.40	4.06	5.13	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	117.08	79.41	9.27	6.96	16.23	1.74	6.38	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	91.76	82.87	9.30	7.28	7.68	4.45	6.87	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	93.10	92.69	12.20	8.94	9.35	4.47	4.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	123.31	2.42	0.32	0.16	0.16	0.00	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	113.36	2.56	0.00	0.00	0.00	0.15	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	132.61	2.85	0.00	0.22	0.00	0.44	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	121.22	2.01	0.00	0.00	0.00	0.25	0.00	2.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	135.41	2.18	0.00	0.00	0.22	0.00	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	112.20	2.95	0.00	0.42	0.00	0.00	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	106.63	2.13	0.00	0.00	0.00	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	164.13	3.31	0.15	0.15	0.00	0.15	0.00	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	136.19	2.41	0.00	0.13	0.13	0.53	0.13	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	118.76	4.32	0.35	0.17	0.00	0.69	0.00	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	128.87	2.84	0.00	0.00	0.00	0.00	0.13	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	122.79	2.91	0.00	0.00	0.24	0.73	0.00	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	123.84	1.81	0.00	0.00	0.26	0.00	0.00	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	177.56	1.90	0.00	0.32	0.63	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	136.82	2.20	0.00	0.00	0.00	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	165.26	3.54	0.00	0.00	0.24	0.24	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	135.84	3.39	0.00	0.16	0.16	0.16	0.00	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	151.47	2.90	0.18	0.18	0.18	0.00	0.00	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	144.03	1.47	0.00	0.21	0.21	0.21	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	156.31	3.91	0.20	0.20	0.00	0.00	0.00	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	132.74	2.95	0.00	0.42	0.21	0.21	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	185.06	3.96	0.33	0.66	0.00	0.33	0.00	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	169.97	3.74	0.00	0.19	0.00	0.37	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	128.58	3.83	0.00	0.38	0.00	0.19	0.19	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	149.20	4.09	0.00	0.82	0.20	0.00	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	171.87	2.42	0.20	0.40	0.00	0.20	0.20	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	171.25	3.51	0.00	0.00	0.27	0.27	0.27	2.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	152.20	2.16	0.00	0.00	0.00	0.00	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	148.68	3.06	0.00	0.24	0.00	0.24	0.00	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	151.81	3.95	0.29	0.00	0.00	0.44	0.15	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	176.52	5.27	0.00	0.42	0.00	0.21	0.21	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	129.55	3.32	0.00	0.17	0.17	0.00	0.00	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	152.39	2.41	0.40	0.20	0.20	0.20	0.00	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	146.57	3.72	0.23	0.00	0.23	0.23	0.00	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	164.82	5.04	0.48	0.00	0.24	0.24	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	183.30	3.58	0.00	0.00	0.00	0.00	0.30	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	135.49	1.91	0.24	0.24	0.24	0.00	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	161.96	3.84	0.20	0.40	0.40	0.00	0.20	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	112.93	5.94	0.00	0.00	0.41	0.20	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	130.09	2.89	0.00	0.22	0.00	0.00	0.00	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	139.46	1.42	0.00	0.00	0.35	0.35	0.35	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	127.25	3.31	0.33	0.00	0.66	0.00	0.00	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	343.13	2.52	0.00	0.00	0.00	0.84	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	260.39	1.84	0.46	0.00	0.92	0.00	0.00	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	95.61	1.94	0.00	0.65	0.00	0.00	0.32	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	92.82	4.18	0.00	0.32	0.64	0.00	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	170.37	2.51	0.00	1.26	0.31	0.00	0.00	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	97.30	1.41	0.00	1.41	0.71	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	110.48	1.12	0.00	0.00	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	169.58	1.59	0.00	1.59	1.59	0.00	0.00	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	145.42	2.72	0.00	0.00	0.34	0.00	0.00	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	105.27	1.62	0.32	0.32	0.97	0.00	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	76.68	4.26	0.00	0.35	0.00	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	86.29	2.93	0.00	0.00	0.49	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	91.24	4.96	0.00	0.50	0.00	0.50	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	94.76	2.81	0.00	0.47	0.00	0.47	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	108.96	3.64	0.00	0.00	0.00	0.00	0.00	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	67.44	1.24	0.00	0.00	0.00	0.62	0.00	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	77.35	1.22	0.00	0.31	0.61	0.00	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	59.55	2.69	0.00	0.16	0.16	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	67.54	1.93	0.16	0.32	0.00	0.16	0.00	1.28
Adipocyte - omental, donor1	11473-119C6	59.80	2.54	0.38	0.13	0.38	0.13	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	166.69	1.49	0.00	0.00	0.75	0.00	0.00	2.24
Adipocyte - omental, donor3	11475-119C8	224.40	2.01	0.00	0.33	0.00	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	187.57	2.55	0.00	0.64	0.00	0.00	0.00	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	142.94	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	158.52	5.87	0.00	0.45	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	192.72	3.30	0.00	0.00	0.35	0.00	0.35	2.26
Adipocyte differentiation, day04, donor1	13019-139D4	97.98	1.56	0.00	0.20	0.00	0.00	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	91.88	2.83	0.00	0.00	0.00	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	109.84	2.51	0.28	0.28	0.28	0.00	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	85.23	1.76	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	68.61	1.85	0.00	0.00	0.32	0.00	0.00	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	71.33	2.26	0.00	0.00	0.65	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	68.25	2.13	0.00	0.00	0.53	0.00	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	82.35	1.67	0.00	0.00	0.00	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	64.88	1.25	0.00	0.42	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	48.22	1.51	0.25	0.00	0.50	0.50	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	54.65	1.64	0.00	0.00	0.00	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	38.67	0.61	0.00	0.30	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	177.24	9.72	0.22	0.00	0.44	1.33	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	221.96	6.45	0.72	0.72	0.36	0.72	0.36	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	113.81	2.40	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	171.45	3.42	0.18	0.18	0.36	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	189.10	3.35	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	138.27	3.29	0.21	0.21	0.21	0.00	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	183.20	2.40	0.00	0.23	0.11	0.11	0.11	0.46
Anulus Pulposus Cell, donor2	11463-119B5	288.75	2.20	0.73	0.00	0.24	0.49	0.00	2.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	217.01	6.29	0.45	0.00	0.90	0.45	0.90	4.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	227.92	4.78	0.00	0.00	0.43	0.87	0.87	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	111.29	8.56	0.00	0.00	0.00	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	188.02	4.18	0.90	0.30	0.60	0.00	0.60	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	233.96	2.53	0.00	0.00	0.00	1.26	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	100.33	2.64	0.00	0.00	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	192.33	5.20	0.32	0.65	0.32	0.32	0.32	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	233.98	5.83	0.49	0.00	2.43	0.49	0.00	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	100.37	5.34	0.00	0.59	0.59	0.00	0.00	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	211.67	7.16	0.38	0.00	0.00	0.00	0.75	4.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	214.07	10.16	0.00	0.00	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	117.86	0.00	0.00	0.00	0.00	0.00	0.00	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	111.53	4.61	0.49	0.16	0.66	0.16	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	174.69	5.46	0.00	1.36	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	112.49	5.88	0.75	0.15	0.15	0.45	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	208.42	4.82	0.54	1.61	0.00	0.00	0.00	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	164.94	5.10	0.76	0.19	0.57	0.19	0.19	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	98.63	4.54	0.80	0.80	0.27	0.00	0.00	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	176.56	3.90	0.00	0.98	0.98	0.00	0.00	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	158.06	6.14	0.66	0.17	1.00	0.83	0.00	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	75.65	6.00	0.00	1.20	1.20	1.20	0.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	162.85	7.08	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	129.33	3.95	0.34	0.69	1.54	0.17	0.69	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	79.70	0.00	0.00	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	222.32	5.34	0.49	0.00	0.97	0.00	0.00	4.37
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	184.79	5.31	0.76	0.00	0.38	0.38	0.00	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	115.08	8.48	0.00	0.00	0.00	2.42	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	250.24	4.56	0.57	0.00	0.00	0.00	0.00	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	163.11	4.49	0.43	0.21	0.21	0.00	0.21	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	96.53	4.39	0.52	0.00	1.03	0.77	0.77	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	221.93	3.28	0.47	0.00	1.41	0.47	0.47	3.28
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	128.94	4.18	0.32	0.32	0.32	0.64	0.64	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	101.31	4.99	0.00	0.00	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	219.94	9.36	1.75	0.00	0.58	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	130.67	3.91	0.00	0.00	0.60	0.30	0.30	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	109.30	8.32	0.00	0.00	3.56	0.00	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	231.90	3.56	0.51	1.53	0.00	0.00	0.00	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	128.36	4.84	1.78	0.25	0.25	0.51	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	94.67	6.99	0.64	0.00	0.64	0.00	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	217.49	5.61	0.00	0.43	0.00	0.43	1.29	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	149.03	5.93	0.00	0.21	0.21	0.21	0.21	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	98.59	4.93	0.29	0.00	0.87	0.00	0.00	1.74
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	192.73	8.50	0.94	0.94	1.89	0.00	0.00	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	146.98	5.76	0.51	0.17	0.85	0.00	0.17	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	76.44	6.95	0.00	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	226.05	6.34	0.00	0.00	0.00	2.11	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	176.25	4.07	0.00	0.21	0.21	0.43	0.21	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	101.08	6.62	0.00	0.00	1.80	0.60	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	259.52	5.10	0.73	0.00	1.46	0.00	0.00	6.56
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	173.10	5.52	0.46	1.15	0.69	0.46	0.00	2.99
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	96.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	108.05	6.61	0.25	0.51	0.25	0.25	1.02	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	152.15	4.75	0.62	0.21	0.83	0.00	0.00	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	91.19	4.59	0.31	0.31	0.92	0.31	0.31	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	244.74	4.78	0.48	0.00	0.96	0.48	0.00	3.82
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	143.47	3.77	0.67	0.22	0.67	0.00	0.22	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	99.18	6.10	0.00	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	225.99	3.88	0.55	0.00	0.00	0.00	0.55	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	126.84	6.62	0.53	0.53	0.53	0.26	0.26	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	96.31	5.82	0.00	0.36	0.36	0.36	0.00	2.18
Astrocyte - cerebellum, donor1	11500-119F6	303.48	7.61	0.61	0.25	0.49	0.12	0.12	0.61
Astrocyte - cerebellum, donor2	11580-120F5	367.14	5.65	0.51	0.68	0.86	1.03	0.00	2.74
Astrocyte - cerebellum, donor3	11661-122F5	202.20	2.31	0.00	0.21	0.42	0.42	0.21	1.68
Astrocyte - cerebral cortex, donor1	11235-116D2	202.88	5.58	0.35	0.35	0.00	0.35	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	141.55	8.74	0.49	0.32	0.32	0.97	0.49	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	137.67	7.61	0.15	0.75	0.30	0.60	0.15	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	117.55	6.31	0.69	0.57	1.03	0.92	0.00	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	105.36	8.64	0.88	1.00	1.75	1.88	0.00	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	94.56	6.15	0.23	0.23	1.37	1.37	0.68	0.57
Basophils, donor1	12241-129G9	138.09	3.40	0.00	0.26	0.26	0.00	0.00	0.52
Basophils, donor2	12242-129H1	147.20	6.13	0.36	0.00	0.00	0.00	0.00	0.36
Basophils, donor3	12243-129H2	118.48	3.82	0.00	0.00	0.15	0.00	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	263.47	5.39	0.00	0.65	0.22	1.94	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	238.65	1.83	0.46	0.00	0.46	0.46	0.00	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	208.03	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	189.55	18.83	0.00	1.88	1.26	1.88	0.63	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	186.12	6.03	0.83	1.04	1.25	1.25	0.21	2.91
Bronchial Epithelial Cell, donor6	11461-119B3	164.20	5.07	0.00	0.46	0.69	0.00	0.23	3.68
Bronchial Epithelial Cell, donor7	11769-123I5	214.49	5.22	0.18	0.00	0.18	0.72	0.18	2.52
Burkitt's lymphoma cell line:DAUDI	10422-106C8	265.47	24.22	5.67	0.31	0.31	0.31	3.19	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	286.94	18.17	1.63	0.23	0.70	0.47	0.70	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	452.16	5.12	0.96	0.00	0.00	0.64	0.32	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	455.05	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	109.33	0.56	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	100.78	2.78	0.00	0.19	0.19	0.00	0.00	1.30
CD14+ Monocytes, donor3	11381-118B4	111.09	2.20	0.00	0.22	0.22	0.00	0.00	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	90.86	3.11	0.00	0.00	0.00	0.00	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	50.04	0.76	0.00	0.00	0.38	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	54.24	0.66	0.00	0.00	0.33	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	93.38	2.31	0.14	0.14	0.14	0.00	0.14	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	102.89	1.51	0.00	0.00	0.00	0.00	0.00	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	99.26	1.90	0.00	0.24	0.00	0.00	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	66.96	1.84	0.00	0.50	0.33	0.00	0.00	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	88.05	1.10	0.00	0.83	0.83	0.28	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	95.20	0.74	0.00	1.74	0.50	0.00	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	74.80	0.98	0.00	0.39	0.78	0.00	0.00	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	91.34	1.42	0.18	0.36	0.53	0.00	0.00	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	144.72	1.96	0.22	0.00	0.00	0.00	0.44	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	73.98	2.34	0.00	0.23	0.47	0.00	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	133.59	1.06	0.00	1.06	0.53	0.00	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	161.97	0.00	0.00	0.00	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	88.51	0.59	0.00	0.15	0.15	0.00	0.15	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	116.34	0.80	0.00	0.20	0.20	0.00	0.00	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	150.11	2.08	0.00	0.42	0.00	0.21	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	103.87	1.60	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	103.83	0.45	0.45	0.23	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	101.70	2.62	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	87.96	1.88	0.27	0.00	0.00	0.00	0.00	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	106.25	1.05	0.35	0.00	0.00	0.00	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	107.73	1.26	0.42	0.42	0.42	0.00	0.00	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	88.18	0.73	0.18	0.18	0.00	0.00	0.00	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	96.87	1.41	0.00	0.00	0.35	0.00	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	100.47	1.75	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	71.84	1.05	0.00	0.17	0.17	0.00	0.17	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	97.75	1.86	0.00	0.00	0.00	0.00	0.00	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	159.51	2.16	0.22	0.00	0.22	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	73.71	1.23	0.00	0.00	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	101.30	1.39	0.00	0.00	0.46	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	128.99	2.32	0.00	0.70	0.00	0.00	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	169.14	2.40	0.00	0.00	0.22	0.00	0.00	1.96
CD14+CD16+ Monocytes, donor2	11801-124D1	201.43	1.85	0.23	0.00	0.00	0.00	0.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	208.17	1.30	0.00	0.22	0.00	0.22	0.00	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	149.65	3.11	0.00	0.00	0.16	0.00	0.00	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	190.36	3.32	0.00	0.00	0.17	0.00	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	125.31	3.12	0.00	0.00	0.00	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	248.54	3.32	0.26	0.00	0.00	0.00	0.00	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	229.23	2.63	0.00	0.00	0.00	0.00	0.00	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	203.39	2.95	0.00	0.00	0.21	0.00	0.00	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	434.91	2.03	0.00	0.00	0.00	0.00	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	494.92	6.78	0.00	0.68	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	481.55	3.11	0.00	0.00	0.00	0.00	0.00	7.25
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	423.77	9.06	2.13	0.00	0.00	0.00	1.60	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	539.82	5.90	0.00	0.00	0.00	0.00	1.07	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	440.12	1.40	0.00	0.00	0.00	0.00	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	477.67	0.78	0.00	0.00	0.00	0.00	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	598.50	2.64	0.00	1.32	0.00	0.00	0.00	6.59
CD19+ B Cells, donor1	11544-120B5	346.84	6.58	0.00	1.64	1.64	0.00	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	311.21	7.25	0.00	1.45	0.73	0.00	0.00	2.18
CD19+ B Cells, donor3	11705-123B4	339.75	4.04	0.50	1.01	1.51	0.00	0.00	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	227.89	11.31	0.00	0.40	0.40	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	194.95	8.79	0.00	0.00	0.00	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	343.38	2.01	0.00	0.00	1.00	0.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	428.66	8.43	0.00	0.00	0.00	0.00	0.00	4.49
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	422.35	11.27	0.75	0.38	0.00	0.38	0.75	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	489.52	7.22	0.68	0.00	0.45	0.90	0.90	0.68
CD4+ T Cells, donor1	11225-116C1	354.91	10.71	0.36	0.00	0.36	0.00	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	345.37	10.41	0.00	0.61	1.22	0.00	0.00	4.90
CD4+ T Cells, donor3	11382-118B5	251.31	12.20	0.30	0.00	0.30	0.00	0.00	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	442.84	3.83	0.00	0.00	0.00	0.00	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	309.94	2.92	0.22	0.00	0.22	0.00	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	276.54	3.74	0.29	0.00	0.00	0.00	0.00	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	665.15	9.48	0.00	0.00	0.00	0.00	0.00	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	894.06	6.32	0.00	0.00	0.00	0.00	0.00	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	543.88	3.30	3.30	0.00	0.00	0.00	0.00	16.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	234.84	2.31	0.00	0.00	0.14	0.00	0.14	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	172.51	3.22	0.34	0.17	0.00	0.00	0.00	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	144.92	2.42	0.00	0.00	0.16	0.00	0.00	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	460.40	8.52	0.45	0.00	0.00	0.00	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	552.73	7.69	0.00	0.00	0.00	0.00	0.00	2.80
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	303.15	5.28	0.00	0.00	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	349.96	2.11	0.00	0.42	0.00	0.00	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	157.49	1.87	0.00	0.00	0.00	0.00	0.00	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	192.46	1.67	0.00	0.00	0.33	0.00	0.33	2.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	514.23	6.80	0.00	0.00	0.00	0.00	0.00	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	842.51	3.75	0.00	0.00	0.00	0.00	0.54	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	485.96	5.38	1.79	0.00	0.00	0.00	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	339.33	3.71	0.00	0.37	0.00	0.00	0.19	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	227.66	4.12	0.22	0.00	0.00	0.00	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	207.84	4.20	0.21	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	613.30	6.57	0.51	0.00	0.00	0.00	1.01	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	615.22	8.23	0.87	0.00	0.00	0.00	0.00	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	437.12	4.79	0.00	0.00	0.00	0.00	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	505.76	6.43	0.00	0.00	0.00	0.00	0.00	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	839.18	1.85	0.00	0.00	0.00	0.00	0.92	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	706.29	2.79	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	911.37	5.26	0.00	0.00	0.00	0.00	0.28	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	893.22	3.44	0.00	0.00	0.25	0.00	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	341.88	6.16	0.00	0.00	0.00	1.54	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	400.73	6.09	0.00	0.00	0.00	0.00	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	523.53	6.92	0.00	0.00	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	358.83	11.79	0.33	0.00	0.33	0.00	0.00	1.64
CD8+ T Cells, donor2	11307-117C2	257.55	14.27	1.13	0.75	0.75	0.00	0.38	4.51
CD8+ T Cells, donor3	11383-118B6	320.16	16.41	0.25	0.00	0.25	0.00	0.50	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	131.90	9.18	0.69	0.46	0.00	0.69	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	107.36	8.63	0.24	0.24	0.48	0.96	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	105.61	9.58	0.55	0.00	0.00	1.92	0.27	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	235.07	7.21	0.30	0.30	0.30	2.10	0.00	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	130.55	7.68	0.48	0.00	0.00	1.20	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	134.84	5.91	0.91	0.23	0.23	0.91	0.00	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	153.84	9.34	1.09	0.22	0.43	1.52	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	157.40	9.21	1.05	0.53	0.79	2.63	0.26	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	114.21	5.39	0.23	1.17	0.47	1.41	0.47	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	120.15	10.57	0.60	0.60	1.21	2.42	0.60	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	118.82	11.91	1.45	0.58	0.00	1.45	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	145.47	9.33	0.80	0.80	0.80	3.46	0.53	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	76.17	5.25	0.44	0.00	0.00	0.88	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	90.63	6.38	1.37	1.37	0.00	0.46	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	64.15	2.98	0.75	0.00	0.00	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	133.62	5.76	0.00	0.72	0.00	0.00	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	115.95	8.06	0.29	0.00	0.00	0.86	0.00	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	86.74	6.36	0.24	0.47	0.71	1.18	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	141.66	7.29	0.95	0.00	0.32	2.85	0.95	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	129.48	10.15	0.62	0.31	0.92	1.23	1.23	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	129.20	9.30	1.60	0.96	0.96	1.92	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	139.22	8.03	0.00	0.38	1.15	2.29	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	105.23	3.94	0.39	0.39	1.58	0.79	0.39	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	94.55	6.05	0.76	0.00	0.00	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	60.22	1.61	1.61	0.80	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	46.86	2.10	1.40	0.00	0.00	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	59.10	2.00	0.00	2.00	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	58.49	1.83	0.00	0.00	0.00	0.00	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	171.94	3.46	0.00	0.49	0.49	0.49	0.49	2.96
Cardiac Myocyte, donor3	11686-122I3	218.67	3.58	0.11	0.32	0.11	0.11	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	177.49	5.89	0.35	0.35	0.69	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	150.32	1.42	0.00	0.00	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	121.74	3.53	0.00	0.11	0.11	0.57	0.00	0.46
Chondrocyte - re diff, donor2	11339-117F7	54.61	1.79	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	82.90	2.83	0.00	0.00	0.00	0.00	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	180.29	6.08	0.00	0.34	0.00	0.11	0.00	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	143.86	5.99	0.43	0.21	0.00	1.50	0.00	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	132.04	4.60	0.27	0.27	0.09	0.44	0.35	1.59
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	71.34	4.03	0.37	0.46	0.55	0.55	0.18	0.09
Corneal Epithelial Cells, donor1	11526-119I5	233.41	2.85	0.22	0.22	0.66	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	194.53	9.10	0.00	0.00	0.00	4.55	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	195.05	7.41	0.00	0.51	1.28	1.79	0.00	2.81
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	38.63	1.82	0.00	0.00	0.00	0.00	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	48.57	2.52	0.00	0.00	0.00	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	38.12	1.51	0.00	0.00	0.00	0.00	0.11	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	221.04	7.52	0.00	0.00	0.00	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	274.86	6.53	0.00	0.65	1.31	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	451.52	3.39	0.48	0.48	0.48	0.00	0.00	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	135.25	7.00	1.33	0.50	0.33	0.67	0.50	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	184.25	4.11	0.00	0.00	0.59	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	197.96	8.20	1.41	0.28	0.57	0.28	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	79.03	7.08	1.18	0.00	0.39	0.00	1.18	1.18
Endothelial Cells - Artery, donor1	11264-116G4	168.42	4.36	0.58	0.29	1.75	0.00	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	124.93	5.88	0.00	0.00	0.94	0.47	0.00	1.41
Endothelial Cells - Artery, donor3	11413-118E9	125.87	6.31	0.53	0.53	0.53	0.53	0.53	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	128.56	3.32	0.00	0.00	0.22	0.00	0.00	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	68.16	1.83	0.61	0.00	0.00	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	80.06	1.69	0.00	0.00	0.00	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	276.63	2.38	0.89	0.00	0.59	0.00	0.00	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	205.14	3.12	1.04	1.04	1.04	1.04	1.04	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	153.70	1.28	0.28	0.00	0.14	0.14	0.00	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	234.07	8.80	1.20	0.40	0.00	2.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	161.43	5.24	0.52	0.00	0.00	1.05	1.05	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	142.88	5.59	0.12	0.50	0.62	0.99	0.25	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	151.65	6.30	1.09	0.43	0.00	0.22	0.22	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	158.16	7.69	0.49	0.49	0.24	0.85	0.49	0.98
Endothelial Cells - Vein, donor1	11267-116G7	172.90	3.41	1.14	0.00	0.00	1.14	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	122.94	6.99	0.70	0.00	0.00	0.70	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	132.36	8.01	0.79	0.63	0.31	0.16	0.31	1.73
Eosinophils, donor1	12244-129H3	213.46	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	39.61	3.30	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	46.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	208.17	5.62	0.00	0.73	0.24	1.71	0.00	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	438.91	6.24	0.00	0.00	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	276.57	0.00	0.00	0.00	0.00	0.00	16.27	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	90.31	3.69	0.00	0.41	0.41	0.00	0.00	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	79.82	5.15	0.22	0.55	0.44	0.55	0.55	4.60
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	166.52	4.33	0.54	0.22	0.33	0.54	0.11	1.30
Fibroblast - Aortic Adventitial, donor1	11245-116E3	128.80	7.40	0.61	0.85	0.49	0.73	0.49	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	60.05	9.28	0.82	0.27	0.41	0.55	0.55	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	100.30	3.38	0.21	0.11	0.53	0.42	0.11	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	91.96	5.01	0.00	0.00	0.26	0.26	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	119.59	3.32	0.00	0.00	0.33	0.66	0.33	1.99
Fibroblast - Cardiac, donor1	11268-116G8	181.90	3.18	0.45	0.00	0.00	0.45	0.00	2.72
Fibroblast - Cardiac, donor2	11345-117G4	104.60	3.03	0.00	1.52	0.76	0.00	0.00	3.03
Fibroblast - Cardiac, donor3	11417-118F4	106.14	5.68	0.47	0.47	0.47	0.63	0.32	0.63
Fibroblast - Cardiac, donor4	11452-119A3	76.99	5.15	0.61	0.30	0.00	0.00	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	193.78	5.84	0.13	0.13	0.25	0.51	0.25	1.52
Fibroblast - Cardiac, donor6	11460-119B2	182.97	6.37	0.45	0.00	0.61	0.15	0.61	1.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	311.66	2.68	0.13	0.00	0.27	0.00	0.00	1.34
Fibroblast - Choroid Plexus, donor2	11572-120E6	139.78	2.16	0.00	0.00	0.00	0.00	0.00	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	171.38	5.86	0.00	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	106.32	11.07	0.69	0.69	1.15	0.46	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	182.49	0.85	0.00	0.00	0.68	0.34	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	227.97	7.98	0.47	0.00	0.47	1.41	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	166.03	14.62	1.89	0.47	0.47	0.94	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	160.29	7.86	0.24	0.48	0.24	0.85	0.12	1.57
Fibroblast - Dermal, donor4	11450-119A1	190.37	5.77	0.68	0.34	0.57	0.90	0.11	1.02
Fibroblast - Dermal, donor5	11454-119A5	278.25	7.15	0.17	0.52	0.52	1.22	0.70	1.92
Fibroblast - Dermal, donor6	11458-119A9	259.55	7.31	0.65	0.97	0.16	1.46	0.32	2.60
Fibroblast - Gingival, donor1	11237-116D4	159.30	3.33	0.21	0.21	0.00	0.83	0.00	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	86.20	3.41	0.26	0.52	0.26	0.00	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	172.90	5.53	0.00	0.40	0.13	2.24	0.26	2.24
Fibroblast - Gingival, donor3	11394-118C8	123.28	1.45	0.10	0.00	0.10	0.48	0.00	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	70.64	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	60.09	3.00	0.00	0.53	0.35	0.18	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	91.67	6.08	0.31	0.78	0.47	0.62	0.16	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	99.12	3.79	0.41	0.41	0.68	1.08	0.00	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	37.76	4.59	1.06	0.71	3.18	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	79.85	3.22	0.29	0.44	0.88	0.44	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	86.04	4.23	0.27	0.55	0.68	0.68	0.27	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	112.87	9.54	0.22	0.55	1.43	1.32	0.44	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	106.68	2.20	0.00	0.29	0.44	0.00	0.00	0.59
Fibroblast - Lung, donor1	11270-116H1	193.03	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	123.85	2.98	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	133.80	3.80	0.21	0.84	0.84	0.00	0.00	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	186.60	7.50	0.00	0.00	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	258.75	0.00	1.40	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	94.04	1.40	0.00	0.00	0.00	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	159.95	5.68	0.00	0.41	0.41	2.03	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	195.72	7.99	0.00	0.00	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	113.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	201.15	6.60	0.00	0.00	0.39	1.16	0.19	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	141.37	6.07	0.00	0.76	0.46	0.91	0.00	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	68.54	7.65	0.31	0.92	0.61	1.22	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	114.11	0.76	0.00	0.38	0.38	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	115.02	3.24	0.00	0.00	0.00	0.00	0.54	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	72.02	2.32	0.12	0.12	0.35	0.23	0.00	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	150.55	11.05	1.33	0.00	0.44	0.66	0.22	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	118.46	2.03	0.00	0.81	0.41	0.61	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	197.12	6.68	0.00	0.67	0.67	1.34	0.00	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	192.94	3.16	0.00	0.00	0.00	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	97.04	5.95	0.20	0.40	0.20	0.40	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	177.26	0.89	0.36	0.00	0.18	0.36	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	179.35	3.55	0.00	0.00	0.20	0.00	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	105.30	8.42	0.00	0.30	0.00	1.81	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	210.18	2.05	0.11	0.11	0.22	0.32	0.00	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	84.53	1.52	0.00	0.00	0.00	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	156.86	2.30	0.00	0.00	0.49	0.00	0.00	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	70.38	8.82	0.40	0.20	0.40	0.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	191.28	3.11	0.10	0.10	0.10	0.10	0.10	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	98.23	3.63	0.00	0.00	0.00	0.30	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	114.08	1.74	0.08	0.00	0.25	0.08	0.08	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	337.11	1.71	0.00	0.00	0.51	0.00	0.00	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	85.72	3.28	0.00	0.33	0.00	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	175.65	3.41	0.11	0.11	0.11	0.11	0.21	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	163.62	5.23	0.00	0.00	0.34	0.17	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	222.53	1.73	0.16	0.16	0.31	0.00	0.00	1.73
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	265.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	163.85	9.59	0.00	0.00	0.87	0.00	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	82.52	8.15	0.52	0.00	0.35	0.17	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	64.80	7.55	0.78	0.52	0.26	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	61.83	7.15	0.26	0.26	0.77	0.77	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	279.43	49.00	3.06	3.83	3.06	3.06	3.06	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	324.78	65.08	5.74	5.10	0.64	2.55	3.83	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	253.31	41.36	1.43	5.13	1.14	3.71	0.29	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	201.30	9.38	0.55	0.00	1.10	0.00	0.00	3.03
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	100.69	6.39	0.46	0.23	1.14	0.23	0.00	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	152.16	22.98	1.78	3.96	0.99	0.79	0.79	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	173.67	9.25	0.26	0.53	0.79	0.53	0.26	4.23
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	84.15	4.89	0.33	0.65	0.65	0.00	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	198.56	32.72	1.77	6.19	4.42	0.88	0.44	3.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	217.78	10.46	0.85	2.12	0.28	2.26	0.42	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	186.44	8.00	0.12	0.62	0.86	1.48	0.12	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	150.43	16.39	0.00	2.15	1.34	1.61	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	158.46	5.58	0.00	0.25	0.00	0.50	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	178.43	5.26	0.00	0.55	0.55	1.66	0.28	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	112.83	10.37	0.00	0.61	0.61	1.42	1.02	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	126.18	3.19	0.00	0.23	0.91	0.46	0.00	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	145.87	3.61	0.12	0.50	0.87	0.75	0.00	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	91.36	3.28	0.00	0.44	0.44	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	156.01	3.55	0.00	0.59	0.30	0.59	0.00	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	140.68	3.18	0.00	0.00	0.32	0.48	0.00	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	99.42	3.13	0.00	0.22	0.22	0.22	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	147.39	5.44	0.20	0.20	0.00	0.00	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	149.62	3.05	0.00	0.17	0.34	0.17	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	88.49	5.05	0.18	0.27	0.09	0.27	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	132.36	2.19	0.00	0.00	0.31	0.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	140.38	3.59	0.00	0.00	0.51	0.34	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	190.77	2.32	0.00	0.22	0.33	0.22	0.11	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	93.68	3.41	0.08	0.50	0.33	0.00	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	127.61	5.10	0.00	0.00	0.00	0.00	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	144.83	3.30	0.00	0.21	0.00	0.21	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	159.80	1.84	0.12	0.12	0.23	0.12	0.00	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	102.89	5.67	0.17	0.17	0.17	0.17	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	146.81	2.87	0.00	0.00	0.22	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	235.28	2.21	0.00	0.37	0.00	0.00	0.00	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	90.12	4.21	0.32	0.00	0.16	0.16	0.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	140.79	1.92	0.00	0.32	0.32	0.00	0.00	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	151.51	2.84	0.19	0.09	0.28	0.19	0.09	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	96.65	2.06	0.00	0.16	0.16	0.00	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	79.06	3.34	0.00	0.30	0.30	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	144.16	3.45	0.10	0.10	0.00	0.52	0.10	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	110.22	1.98	0.00	0.44	0.22	0.00	0.00	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	98.19	2.24	0.00	0.00	1.12	0.28	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	70.18	2.59	0.28	0.09	0.28	0.19	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	48.13	4.01	0.00	0.53	0.27	0.27	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	67.32	4.13	0.31	0.15	0.15	0.15	0.15	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	90.55	5.57	0.39	0.39	0.52	0.26	0.13	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	71.29	2.98	0.00	0.27	0.27	0.27	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	92.36	3.69	0.37	0.18	0.00	0.00	0.00	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	93.21	2.63	0.00	0.00	0.00	0.22	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	61.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	69.78	2.77	0.13	0.13	0.26	0.00	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	79.09	4.24	0.00	0.20	0.00	0.20	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	39.90	0.51	0.25	0.25	0.25	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	298.59	16.32	0.20	1.19	1.59	2.19	1.00	2.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	230.50	9.71	0.46	1.69	0.62	2.00	0.00	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	216.86	18.41	0.00	1.64	1.02	1.23	0.00	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	217.80	39.12	0.94	1.88	1.25	1.56	1.56	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	203.16	35.60	2.54	1.70	2.26	2.54	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	212.15	32.28	1.38	0.46	0.46	0.46	1.84	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	254.90	29.70	4.95	0.00	2.47	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	208.88	31.33	1.16	1.93	1.55	1.93	1.93	5.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	259.92	44.93	0.00	0.00	0.00	0.00	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	198.23	22.60	3.48	1.74	0.00	0.00	0.00	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	223.28	14.65	0.33	1.30	0.33	1.30	0.00	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	207.55	24.71	1.24	0.82	0.41	0.41	0.41	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	123.29	10.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	212.53	10.07	0.56	0.84	0.56	1.68	0.00	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	198.07	14.38	0.33	0.98	0.33	0.98	0.00	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	197.13	8.39	0.00	2.52	0.84	0.00	0.84	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	227.10	13.68	0.32	0.32	0.64	1.91	0.00	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	204.14	11.55	0.34	1.36	1.02	0.68	0.00	2.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	315.31	14.62	0.00	0.00	2.09	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	312.69	10.31	0.00	0.00	1.15	0.57	0.00	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	215.18	8.88	0.00	0.30	0.59	0.00	0.00	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	174.50	8.47	0.00	0.00	1.69	0.00	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	218.70	14.91	0.00	0.83	0.41	0.41	0.41	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	229.44	13.35	0.46	0.92	1.15	0.23	0.23	2.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	163.32	15.81	0.00	0.00	0.00	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	184.52	11.15	0.00	1.15	0.00	0.00	0.38	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	201.12	5.87	0.00	0.33	0.98	0.65	0.33	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	269.54	2.68	0.00	2.68	0.67	0.67	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	332.10	5.78	0.39	0.00	0.00	0.00	0.00	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	222.52	18.49	0.34	1.71	0.68	0.00	1.03	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	236.05	4.97	0.00	0.00	0.00	0.00	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	342.09	3.30	0.47	0.00	0.00	0.94	0.00	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	270.97	8.45	0.00	0.00	0.00	0.00	0.00	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	272.14	5.60	0.00	1.02	0.51	0.51	1.02	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	336.62	8.77	0.80	0.40	0.00	0.80	0.00	5.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	327.09	1.97	0.00	0.00	0.00	0.49	0.00	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	330.52	4.72	0.00	0.00	1.18	0.00	0.00	16.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	379.82	7.00	0.00	0.00	0.58	0.00	0.00	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	277.37	3.07	0.00	0.44	0.00	0.88	0.00	6.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	222.10	8.48	0.85	1.70	0.85	0.00	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	164.15	4.78	0.60	0.60	0.00	0.60	0.60	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	214.96	9.70	0.00	0.00	0.49	0.49	0.49	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	146.09	5.71	0.00	0.00	0.00	0.00	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	89.40	1.66	0.00	0.00	0.42	0.00	0.00	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	92.21	4.50	0.00	0.00	0.00	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	221.38	2.85	0.32	0.32	0.00	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	257.75	2.92	0.00	0.00	0.00	0.00	0.42	3.34
Hep-2 cells mock treated, biol_rep1	11898-125E8	106.99	5.69	0.46	0.81	1.39	0.70	0.12	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	99.42	6.08	0.00	0.68	0.68	0.51	0.00	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	109.66	7.74	0.46	0.46	0.46	0.68	0.00	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	100.67	7.54	0.33	0.55	0.44	0.98	0.33	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	105.52	6.23	0.00	1.29	0.64	0.43	0.00	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	101.83	7.32	0.65	0.22	0.65	0.43	0.22	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	117.44	5.60	0.37	1.12	1.00	0.87	0.50	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	93.32	6.00	0.17	0.34	0.34	0.86	0.00	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	106.36	4.81	0.00	0.32	1.28	0.00	0.32	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	235.60	2.24	0.56	0.00	0.00	1.12	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	138.49	3.03	0.43	0.00	0.43	0.87	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	97.82	7.93	0.00	2.64	0.00	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	217.63	6.35	0.35	0.71	0.35	0.00	0.35	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	176.54	5.81	0.00	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	145.29	10.14	1.22	0.35	0.17	1.92	0.52	1.57
Hepatocyte, donor1	11523-119I2	60.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	66.79	1.08	0.00	1.08	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	82.21	2.45	0.00	0.00	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	110.96	16.32	0.00	0.00	0.65	0.00	1.96	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	94.56	4.19	0.00	0.70	0.00	0.52	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	113.74	5.49	0.14	0.27	0.41	0.69	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	426.64	12.74	0.00	3.18	0.00	0.00	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	307.06	6.68	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	287.95	15.23	0.00	1.38	1.38	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	265.28	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	271.67	23.07	0.00	2.56	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	292.53	9.14	0.00	4.57	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	199.79	24.36	1.62	3.25	1.62	3.25	1.62	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	270.10	15.01	0.00	0.00	0.00	1.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	265.03	21.78	0.00	3.63	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	170.73	22.50	0.00	1.32	1.32	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	262.75	18.85	0.00	1.11	0.00	6.65	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	350.96	15.71	0.00	10.48	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	272.73	14.49	0.63	3.15	5.04	3.15	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	253.65	12.37	3.09	0.00	0.00	3.09	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	204.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	295.24	13.57	0.65	4.52	5.17	5.17	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	247.93	19.32	0.00	11.27	6.44	0.00	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	340.62	15.48	0.81	4.07	4.89	4.07	0.00	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	222.50	16.79	0.84	6.72	2.94	2.52	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	273.08	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	274.06	14.47	0.80	4.02	6.43	2.41	0.80	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	234.51	13.85	0.00	3.69	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	135.73	15.08	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	308.24	15.11	0.47	4.25	2.36	2.36	0.47	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	256.68	19.95	0.91	3.63	1.81	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	147.42	14.74	0.00	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	299.16	13.99	0.00	3.23	2.15	6.46	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	275.69	11.43	0.00	5.08	2.54	5.08	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	16.43	0.00	0.00	0.00	16.43	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	292.69	15.94	1.28	5.10	2.55	4.46	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	266.11	16.40	0.00	5.47	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	237.07	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	264.92	16.42	2.86	7.14	1.43	5.71	0.00	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	328.51	9.95	3.32	13.27	3.32	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	259.58	14.20	0.31	3.40	2.47	4.01	0.31	2.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	321.35	17.56	1.76	3.51	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	333.17	9.43	0.00	3.14	3.14	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	287.20	17.38	0.00	2.78	6.26	5.56	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	285.49	13.28	0.00	0.00	2.21	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	304.75	12.97	0.00	0.00	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	285.12	6.98	0.00	1.74	0.87	0.87	0.87	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	321.72	9.00	0.00	2.25	2.25	0.00	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	254.37	6.97	0.00	3.48	0.00	3.48	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	304.03	9.60	0.00	1.07	3.20	2.13	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	205.05	9.70	0.00	5.54	5.54	2.77	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	265.01	14.25	0.00	5.70	2.85	8.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	266.92	16.57	0.92	3.68	0.00	1.84	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	311.61	3.03	0.00	3.03	0.00	6.05	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	322.85	12.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	301.35	5.29	0.00	1.06	0.00	2.11	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	86.58	5.39	0.82	0.65	0.90	1.39	0.08	0.33
Keratinocyte - epidermal, donor2	11349-117G8	117.13	4.10	0.00	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	127.50	5.02	0.19	0.66	0.28	0.66	0.19	1.23
Keratinocyte - oral, donor1	11251-116E9	223.74	4.20	0.11	0.00	0.23	0.79	0.00	0.91
Keratocytes, donor1	11527-119I6	169.17	8.94	0.00	0.00	0.69	0.00	0.00	0.69
Keratocytes, donor2	11607-120I5	176.94	5.86	0.00	0.00	1.17	2.34	0.00	1.17
Keratocytes, donor3	11688-122I5	112.24	1.19	0.00	0.59	0.20	0.20	0.00	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	2.20	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	196.33	10.79	0.00	0.00	1.08	0.00	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	184.42	2.88	0.23	0.12	0.00	0.23	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	107.17	3.43	0.50	0.00	0.20	0.30	0.30	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	104.47	3.79	0.47	0.12	0.12	0.71	0.12	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	112.19	2.51	0.00	0.00	0.56	0.56	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	118.22	4.56	0.16	0.16	0.00	0.94	0.31	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	183.36	8.07	0.54	0.00	0.00	1.08	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	105.90	1.26	0.32	0.00	0.32	0.32	0.32	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	129.49	3.88	0.22	0.00	0.22	0.43	0.11	2.16
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	146.51	4.10	0.00	0.41	0.00	0.82	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	158.52	5.06	0.25	0.51	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	119.36	3.66	0.14	0.28	0.00	0.28	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	156.24	5.14	0.00	0.00	0.00	0.40	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	135.33	4.46	0.00	0.19	0.00	0.00	0.19	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	142.93	5.18	0.19	0.00	0.00	0.19	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	166.55	3.14	0.70	0.00	0.00	0.00	0.00	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	117.59	3.34	0.00	0.00	0.24	0.48	0.00	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	124.85	3.43	0.00	0.27	0.41	0.69	0.27	2.06
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	158.29	3.39	0.62	0.00	0.62	0.62	0.00	2.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	123.45	3.12	0.00	0.31	0.00	0.00	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	121.14	4.94	0.37	0.00	0.18	0.00	0.00	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	175.75	5.59	0.33	0.00	0.00	0.33	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	127.11	3.22	0.00	0.29	0.29	0.29	0.00	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	155.08	5.73	0.25	0.00	0.00	0.25	0.00	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	171.68	4.85	0.97	0.48	0.00	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	137.07	3.50	0.54	0.00	0.27	0.27	0.27	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	135.94	4.24	0.00	0.15	0.00	0.61	0.00	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	160.19	5.18	0.00	0.00	1.04	0.52	0.00	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	113.70	3.98	0.42	0.00	0.42	0.00	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	115.03	3.16	0.00	0.15	0.15	0.15	0.45	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	192.61	6.19	1.38	0.00	0.00	0.00	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	117.78	4.70	0.00	0.00	0.19	0.38	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	131.05	3.50	0.32	0.11	0.21	0.64	0.00	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	132.29	5.33	0.48	0.00	0.48	1.94	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	99.90	3.97	0.00	0.00	0.00	0.00	0.33	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	127.48	3.10	0.12	0.25	0.12	0.50	0.37	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	139.20	5.92	0.74	0.00	0.37	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	92.66	3.21	0.25	0.00	0.25	0.00	0.25	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	129.93	2.89	0.14	0.00	0.14	0.00	0.27	1.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	151.17	2.57	0.00	0.00	0.00	0.32	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	92.82	4.26	0.30	0.00	0.00	0.00	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	133.53	2.52	0.28	0.00	0.14	0.00	0.14	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	165.69	3.20	0.00	0.00	0.36	0.71	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	129.44	5.82	0.00	0.00	0.00	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	136.62	2.80	0.16	0.31	0.16	0.31	0.16	1.40
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	213.43	4.30	0.00	0.36	0.00	0.72	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	119.89	3.92	0.00	0.33	0.33	0.00	0.65	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	138.66	4.24	0.00	0.24	0.47	0.71	0.24	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	107.54	4.21	0.50	0.25	0.00	0.50	0.25	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	120.38	3.07	0.00	0.00	0.51	1.28	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	205.57	3.58	0.00	0.00	0.00	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	90.64	4.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	203.29	3.07	0.00	0.77	0.00	0.00	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	235.29	2.23	0.00	0.00	2.23	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	133.29	9.31	0.85	0.00	0.00	0.00	0.42	8.04
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	193.41	4.22	0.70	0.00	0.70	0.70	0.70	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	260.58	9.34	0.93	0.00	0.00	0.00	0.00	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	142.21	5.67	0.00	0.52	0.00	0.00	1.03	7.21
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	214.10	4.76	1.19	0.00	0.00	0.00	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	177.56	5.20	0.68	0.00	0.00	0.23	0.23	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	132.04	8.43	0.58	0.00	0.58	0.29	0.29	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	203.93	6.75	0.45	0.00	0.45	0.45	0.00	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	145.51	5.55	0.41	0.27	0.00	0.54	0.14	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	138.14	5.14	0.51	1.03	0.51	0.00	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	199.36	4.23	1.06	0.35	0.00	0.35	0.35	2.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	177.90	3.33	0.00	0.00	0.00	0.00	0.67	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	151.29	5.09	1.02	0.00	0.00	0.00	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	192.63	6.67	0.00	0.27	0.00	0.53	0.27	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	164.76	5.29	0.57	0.00	0.19	0.76	0.57	3.21
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	157.07	4.29	0.00	0.61	0.61	1.23	0.00	6.14
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	206.30	7.34	1.63	0.00	0.00	0.00	0.00	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	177.22	5.41	0.42	0.21	0.21	1.04	0.21	3.33
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	167.32	4.76	0.84	0.00	0.00	0.56	0.00	5.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	186.49	5.15	1.03	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	163.73	3.77	0.58	0.00	0.29	0.29	0.58	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	130.33	5.38	0.60	0.30	0.00	0.00	0.30	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	171.51	6.09	0.00	1.11	0.00	0.55	0.00	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	195.83	7.07	0.35	0.35	0.00	0.00	0.35	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	137.19	5.90	0.37	0.37	0.37	1.48	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	246.37	5.76	0.00	0.00	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	176.53	5.76	0.38	0.77	0.38	0.38	0.00	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	121.72	7.36	0.00	0.57	0.00	1.13	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	220.71	5.74	0.00	0.00	0.82	0.00	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	149.57	4.07	0.45	0.00	0.45	0.00	0.00	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	151.53	5.03	0.00	0.00	0.00	1.44	0.00	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	206.89	2.99	0.00	1.49	0.00	1.49	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	138.23	4.46	1.11	0.00	0.00	0.00	0.74	3.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	146.88	5.17	0.43	1.29	0.43	0.43	0.00	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	212.36	0.86	0.00	0.86	0.86	0.86	0.86	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	170.59	5.66	0.67	0.33	0.33	0.33	0.33	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	126.69	4.22	0.60	0.60	0.60	1.81	0.00	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	196.95	4.27	0.71	0.00	0.71	0.00	0.71	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	166.70	5.16	0.00	0.69	0.34	0.00	0.34	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	169.08	6.98	0.00	0.54	0.00	1.07	0.54	5.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	201.33	3.37	0.00	0.00	0.00	0.00	0.00	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	155.57	2.96	0.00	0.37	0.00	0.74	0.00	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	122.11	2.33	2.33	1.16	0.00	0.00	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	149.14	1.06	2.12	2.12	0.00	0.00	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	165.26	4.00	0.00	0.40	0.00	0.00	0.80	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	143.19	7.27	1.45	0.00	0.73	2.18	0.00	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	252.18	10.73	0.77	0.00	0.00	0.00	0.00	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	203.23	4.93	0.99	0.49	0.99	0.99	0.00	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	102.56	8.47	0.94	0.00	0.94	1.88	0.94	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	226.27	9.55	0.50	0.00	1.51	0.50	2.01	4.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	153.66	6.76	0.00	0.00	0.00	0.45	0.90	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	144.57	6.88	0.00	0.00	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	232.47	4.90	0.45	0.00	0.00	1.34	0.00	4.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	158.37	9.38	0.78	0.00	0.00	0.00	0.78	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	147.78	4.62	0.66	0.00	0.66	0.00	0.00	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	235.07	5.19	0.00	1.04	0.00	0.00	0.52	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	148.34	3.06	0.00	0.44	0.44	0.88	0.44	3.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	136.98	9.50	0.00	0.00	0.56	2.24	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	221.26	5.30	0.88	0.00	0.00	0.44	0.00	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	193.24	7.71	0.39	0.00	0.39	0.77	0.00	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	139.25	7.60	0.51	0.00	0.51	1.01	0.00	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	205.71	7.69	1.92	0.96	0.00	0.00	0.96	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	163.39	9.54	0.00	0.40	0.00	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	150.08	7.90	0.00	0.00	0.00	1.22	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	296.05	5.53	1.38	0.00	0.00	0.00	0.00	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	182.40	5.70	0.76	0.00	0.00	0.76	0.38	4.56
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	179.20	10.33	1.03	1.03	0.00	0.52	0.52	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	288.42	6.05	0.60	0.60	0.00	0.60	0.00	4.23
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	206.94	6.97	0.32	0.63	0.32	0.32	0.63	4.12
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	143.93	7.46	0.53	0.53	0.00	0.53	1.07	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	366.07	5.75	0.00	0.00	0.57	0.57	1.72	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	199.52	7.71	2.06	0.00	0.51	1.03	0.00	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	137.93	6.37	0.71	0.00	0.00	0.71	0.00	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	348.44	4.54	0.57	0.00	0.57	0.57	0.57	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	151.85	8.32	0.42	0.42	0.00	0.42	0.42	4.16
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	156.61	7.83	0.00	0.00	1.57	0.00	0.00	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	361.60	5.01	1.25	0.00	1.25	1.25	0.42	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	201.19	6.97	0.46	0.46	0.00	0.00	0.46	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	175.96	5.35	0.67	0.67	0.00	0.67	1.34	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	389.22	6.95	0.00	0.00	0.00	1.07	0.53	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	179.42	5.25	0.00	0.81	0.40	0.81	0.00	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	170.70	13.77	0.92	0.00	0.00	0.00	0.00	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	416.99	11.56	0.00	0.00	0.00	0.89	0.00	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	197.74	7.41	1.71	0.00	0.00	1.14	0.00	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	164.88	7.67	1.53	0.00	0.00	0.00	0.00	5.37
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	314.08	6.57	0.55	0.00	1.09	2.74	0.55	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	152.34	8.02	0.00	0.45	0.00	0.45	0.00	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	172.87	8.32	1.30	1.04	0.00	0.78	0.78	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	373.33	12.60	0.00	0.00	0.00	0.00	1.99	4.64
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	261.90	10.39	0.00	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	47.86	1.37	0.00	0.23	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	33.21	1.65	0.00	0.00	0.00	0.18	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	43.91	1.44	0.00	0.26	0.13	0.13	0.00	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	122.67	7.97	0.00	1.59	0.00	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	79.38	3.01	0.00	0.63	0.32	0.63	0.32	0.48
Mallassez-derived cells, donor3	11930-125I4	153.16	7.37	0.69	1.39	0.97	0.69	0.28	0.42
Mammary Epithelial Cell, donor1	11273-116H4	65.86	7.37	0.10	0.50	0.20	0.40	0.30	0.30
Mammary Epithelial Cell, donor2	11350-117G9	153.17	5.79	0.00	0.29	0.00	1.16	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	117.48	5.24	0.50	0.00	0.25	1.50	0.00	1.25
Mast cell - stimulated, donor1	11487-119E2	16.27	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	85.32	1.84	0.00	0.22	0.22	0.00	0.11	0.43
Mast cell, donor2	11565-120D8	123.62	2.38	0.30	0.00	0.00	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	125.17	3.38	0.00	0.23	0.00	0.00	0.45	0.68
Mast cell, donor4	11567-120E1	115.59	1.77	0.00	0.00	0.00	0.00	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	48.35	1.66	0.00	0.00	0.11	0.11	0.11	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	61.29	4.09	0.58	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	81.91	2.29	0.00	0.00	0.00	0.00	0.00	0.34
Mast cell, expanded, donor8	11941-126A6	76.49	3.85	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	165.86	3.98	0.20	0.30	0.10	0.20	0.20	0.70
Melanocyte - dark, donor2	11582-120F7	199.34	4.15	0.35	0.00	0.35	1.38	0.69	1.38
Melanocyte - dark, donor3	11663-122F7	77.00	3.91	0.00	0.00	0.07	0.29	0.14	0.29
Melanocyte - light, donor1	11274-116H5	57.12	0.24	0.00	0.24	0.24	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	73.02	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	56.37	0.00	0.00	0.00	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	128.28	3.44	0.00	0.21	0.00	0.94	0.00	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	96.28	4.03	0.00	0.00	0.00	1.88	0.00	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	119.20	3.75	0.00	0.00	0.27	0.27	0.00	0.54
Meningeal Cells, donor1	11493-119E8	255.07	6.95	0.50	0.25	0.12	0.37	0.25	0.37
Meningeal Cells, donor2	11573-120E7	346.40	5.28	0.88	0.44	0.44	0.00	0.00	1.32
Meningeal Cells, donor3	11654-122E7	120.30	8.23	0.33	0.41	0.33	1.14	0.16	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	180.79	6.56	0.00	0.29	0.29	0.57	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	87.65	4.43	0.00	0.00	0.00	0.40	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	82.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	147.82	5.23	0.00	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	121.28	10.05	0.72	1.44	0.72	0.72	0.72	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	106.31	3.18	0.00	0.21	0.00	0.00	0.00	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	86.96	1.51	0.00	0.00	0.00	0.00	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	176.46	12.31	0.00	1.10	0.66	1.54	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	197.99	11.69	0.00	1.46	0.73	1.46	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	162.45	9.41	1.23	1.43	0.41	0.61	0.20	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	360.95	1.66	0.14	0.00	0.00	0.28	0.14	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	152.78	3.72	0.00	0.00	0.74	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	159.86	3.03	0.00	0.00	0.00	0.39	0.00	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	240.66	2.08	0.00	0.00	0.00	0.30	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	158.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	156.90	7.04	0.00	0.64	0.64	1.28	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	190.34	10.63	0.35	0.71	0.00	1.06	0.71	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	271.76	3.13	0.31	0.00	0.63	0.00	0.00	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	254.72	14.51	0.00	3.63	0.00	6.53	0.73	1.45
Mesothelial Cells, donor1	11247-116E5	68.15	3.45	0.53	0.27	0.00	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	56.05	4.00	1.50	0.50	0.50	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	48.35	2.53	0.07	0.22	0.14	0.00	0.22	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	1.35	0.00	0.00	1.35	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	55.66	1.48	0.00	0.25	0.25	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.04	1.77	0.00	0.29	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	50.21	1.24	0.31	0.00	0.31	0.00	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	32.57	1.04	0.00	0.21	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	61.06	1.75	0.00	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.51	1.40	0.00	0.00	1.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	46.74	0.81	0.20	0.00	0.00	0.00	0.00	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	30.09	1.58	0.00	0.40	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	61.06	0.00	0.00	0.00	0.00	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.02	1.14	0.00	0.76	0.76	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	43.72	1.06	0.00	0.42	0.00	0.21	0.21	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.70	0.30	0.00	0.30	0.00	0.00	0.00	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	40.40	1.76	0.00	0.00	0.00	0.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.64	0.95	0.00	0.48	0.00	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	41.67	0.92	0.00	0.00	0.00	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	28.61	0.63	0.00	0.00	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	23.03	0.82	0.20	0.20	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	41.41	1.72	0.00	0.21	0.43	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	23.56	0.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	38.55	1.31	0.00	0.00	0.44	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	18.76	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.25	1.63	0.00	0.27	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.70	1.47	0.00	0.00	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	49.50	2.88	0.00	0.00	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.61	0.40	0.40	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	45.05	0.00	0.00	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	31.97	0.88	0.00	0.00	0.44	0.00	0.00	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.29	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.77	0.74	0.00	0.00	0.25	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.85	2.05	0.00	0.68	0.34	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	0.00	0.44	0.00	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.60	1.07	0.00	0.00	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	30.02	2.24	0.00	0.28	0.56	0.00	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.70	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.74	0.00	0.00	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	23.83	0.30	0.30	0.00	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	26.71	1.25	0.00	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	1.85	0.00	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	2.28	0.00	0.57	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	26.12	0.41	0.00	0.14	0.00	0.00	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.18	1.55	0.00	0.00	0.26	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	28.74	0.86	0.00	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.08	1.60	0.00	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.14	1.20	0.00	0.00	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.97	0.00	0.00	0.00	0.14	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.43	0.00	0.00	0.32	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	23.00	1.33	0.00	0.00	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.99	0.76	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	1.70	0.00	0.00	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.63	0.98	0.00	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.85	1.30	0.00	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.17	1.76	0.00	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	35.46	1.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	16.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.46	1.19	0.00	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	82.87	0.00	0.00	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	76.64	0.00	0.00	0.00	0.00	0.00	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	45.34	0.33	0.00	0.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	47.34	3.16	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	57.53	0.79	0.00	0.00	0.20	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	64.26	1.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	52.20	1.13	0.00	0.38	0.00	0.00	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	47.14	0.27	0.00	0.00	0.00	0.27	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	56.32	1.13	0.00	0.11	0.00	0.00	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	53.04	1.47	0.00	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.38	0.37	0.00	0.37	0.00	0.00	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	49.78	0.00	0.00	0.00	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	72.15	1.07	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	100.46	0.00	0.00	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	49.49	2.02	0.00	0.00	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	47.22	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	87.16	6.81	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	138.60	1.27	0.00	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	94.75	2.43	0.00	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	75.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	222.70	11.42	22.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	176.17	26.10	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	0.00	4.75	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	250.98	25.10	25.10	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	132.49	4.52	0.22	0.43	0.65	0.00	1.29	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	126.99	0.00	0.00	0.52	0.00	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	58.74	2.67	0.67	0.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	34.64	0.83	0.00	0.00	0.42	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	104.39	4.56	0.00	0.38	0.19	0.19	0.00	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	170.76	1.60	0.00	0.00	1.60	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	25.16	0.68	0.00	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	40.60	2.09	0.00	0.42	0.84	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	45.56	3.02	0.23	0.00	1.63	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	72.69	2.43	0.00	0.54	0.00	0.00	0.00	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	84.73	2.31	0.00	0.21	0.63	0.00	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	60.06	1.99	0.50	0.50	0.99	0.00	0.50	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	83.37	1.89	0.00	0.00	0.00	0.00	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	62.34	0.68	0.00	0.45	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	46.87	0.65	0.33	0.00	0.65	0.49	0.16	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	89.12	1.28	0.18	0.00	0.36	0.00	0.18	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	75.85	2.65	0.53	0.53	0.00	0.00	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	53.43	1.80	0.00	0.00	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	130.61	1.31	0.33	0.33	0.00	0.33	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.32	0.98	0.16	0.49	0.65	0.16	0.16	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	95.07	1.06	0.18	0.53	0.00	0.00	0.18	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	66.10	0.70	0.00	0.70	0.00	0.00	0.70	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	70.80	1.84	0.46	0.46	0.92	0.00	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	71.02	1.93	0.32	0.00	0.32	0.00	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	166.93	2.41	0.00	0.34	0.34	0.34	0.00	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	116.31	2.53	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	72.63	2.01	0.00	0.22	0.45	0.00	0.00	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	47.84	3.39	0.42	0.85	0.85	1.27	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	71.44	1.42	0.00	0.47	0.71	0.24	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	61.38	1.29	0.00	0.43	0.00	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	90.30	1.00	0.33	0.67	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	48.69	4.96	0.45	0.00	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	42.46	2.38	0.79	0.00	0.40	0.40	0.40	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	60.36	0.93	0.00	0.00	0.00	0.00	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	77.19	2.65	0.00	0.00	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	43.99	0.98	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	63.19	0.00	0.00	0.00	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	79.60	2.71	0.45	0.00	0.00	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	52.91	2.65	0.88	0.00	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	54.52	1.99	0.00	1.33	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	58.53	0.99	0.50	0.50	1.98	0.50	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	48.62	0.38	0.00	0.77	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	106.46	1.51	0.00	0.00	0.00	0.00	0.00	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	54.59	2.43	0.00	0.22	0.22	0.22	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	50.82	1.36	0.68	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	66.42	10.22	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	61.58	1.83	0.00	0.00	0.00	0.00	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	37.45	0.00	0.31	0.63	0.31	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	59.62	0.30	0.00	0.00	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	51.42	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	114.50	1.13	0.00	1.13	0.00	0.00	1.13	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	79.63	10.06	1.49	0.75	0.87	0.37	0.37	0.62
Myoblast, donor2	11322-117D8	117.37	4.79	0.19	0.77	0.00	0.38	0.00	1.92
Myoblast, donor3	11398-118D3	74.50	5.89	0.17	0.17	0.34	0.17	0.67	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	118.21	6.71	1.46	0.29	0.15	0.00	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	261.08	7.38	1.23	0.00	0.31	0.00	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	208.98	10.55	0.00	1.81	0.90	0.30	0.00	2.41
Natural Killer Cells, donor3	11387-118C1	212.95	8.10	0.37	0.37	0.00	0.18	0.55	0.55
Neural stem cells, donor1	11275-116H6	38.11	6.90	0.00	0.00	0.73	0.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	63.55	1.93	1.93	0.00	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	129.72	12.52	1.14	0.00	0.00	0.00	0.00	1.14
Neurons, donor2	11574-120E8	100.17	6.38	0.00	0.00	0.22	0.44	0.00	0.22
Neurons, donor3	11655-122E8	92.90	11.51	1.64	0.00	0.00	0.00	0.00	1.64
Neutrophils, donor1	11233-116C9	9.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	28.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	9.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	204.11	2.26	0.00	0.00	0.00	0.24	0.00	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	144.24	1.30	0.00	0.00	0.33	0.33	0.00	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	377.84	2.01	0.20	0.00	0.20	0.60	0.00	2.61
Olfactory epithelial cells, donor1	11933-125I7	76.81	1.65	0.00	0.28	0.14	0.00	0.00	0.55
Olfactory epithelial cells, donor2	11934-125I8	95.24	4.78	0.29	0.58	1.16	0.14	0.14	2.75
Olfactory epithelial cells, donor3	11935-125I9	94.44	3.41	0.11	0.34	0.11	0.23	0.00	1.14
Olfactory epithelial cells, donor4	11936-126A1	103.14	1.95	0.00	0.29	0.00	0.00	0.00	1.36
Oligodendrocyte - precursors, donor1	11496-119F2	119.76	1.81	0.00	0.00	0.00	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	200.15	2.55	0.00	0.43	0.43	0.00	0.64	0.64
Osteoblast - differentiated, donor2	11353-117H3	102.88	2.29	0.00	1.14	1.14	0.00	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	202.97	2.48	0.00	0.00	0.00	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	215.37	6.64	0.59	0.59	0.59	0.78	0.39	1.17
Osteoblast, donor2	11354-117H4	117.29	8.43	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	128.68	8.00	0.89	0.36	0.00	0.53	0.18	0.71
Pancreatic stromal cells, donor1	11249-116E7	119.02	4.21	0.17	0.34	0.17	0.42	0.08	0.67
Pericytes, donor1	11491-119E6	262.03	1.67	0.00	0.00	0.00	0.11	0.00	0.45
Pericytes, donor2	11571-120E5	355.17	1.13	0.00	0.00	0.45	0.23	0.00	1.58
Pericytes, donor3	11652-122E5	206.91	7.32	0.20	0.00	0.41	0.20	0.61	1.22
Perineurial Cells, donor1	11499-119F5	198.24	6.22	0.11	0.11	0.34	0.23	0.00	0.45
Perineurial Cells, donor2	11579-120F4	137.56	2.85	0.37	0.28	0.00	0.09	0.00	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	181.04	6.06	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	107.98	3.18	0.00	0.24	0.00	0.00	0.00	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	149.09	5.05	0.00	0.26	0.39	0.00	0.00	0.91
Placental Epithelial Cells, donor1	11278-116H9	100.69	5.98	0.48	0.00	0.48	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	131.96	2.22	0.00	0.00	2.22	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	137.63	3.93	0.20	0.59	0.00	0.20	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	75.00	2.22	0.32	0.32	0.00	0.00	0.00	0.95
Preadipocyte - breast, donor1	11467-119B9	57.78	2.44	0.19	0.56	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	34.72	2.09	0.00	0.00	0.13	0.00	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	91.86	3.15	0.23	0.00	0.00	0.00	0.23	1.13
Preadipocyte - omental, donor1	11468-119C1	62.44	3.20	0.11	0.11	0.00	0.11	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	32.30	3.49	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	55.01	4.58	0.43	0.00	0.14	0.43	0.00	0.43
Preadipocyte - perirenal, donor1	11469-119C2	237.21	5.91	0.98	0.00	0.00	0.00	0.00	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	110.87	10.13	1.54	0.00	0.00	1.54	0.00	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	91.02	10.98	0.89	0.35	0.18	0.71	0.18	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	112.73	7.32	0.34	0.17	0.17	0.17	0.00	1.02
Preadipocyte - visceral, donor1	11280-116I2	95.48	8.48	0.19	0.09	0.47	0.93	0.28	0.09
Preadipocyte - visceral, donor2	11357-117H7	51.08	7.36	0.00	0.46	0.92	1.84	0.46	0.92
Preadipocyte - visceral, donor3	11429-118G7	196.34	8.36	0.42	0.21	0.42	1.04	0.31	2.40
Prostate Epithelial Cells (polarized), donor1	11253-116F2	110.73	6.49	0.45	0.91	0.30	1.21	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	50.37	5.82	0.27	0.14	0.27	0.54	0.41	0.95
Prostate Epithelial Cells, donor3	11404-118D9	85.55	3.31	0.12	0.43	0.18	1.10	0.00	0.49
Prostate Stromal Cells, donor1	11254-116F3	113.10	9.34	0.68	0.68	0.46	1.59	0.11	0.46
Prostate Stromal Cells, donor2	11332-117E9	91.08	11.12	0.72	0.72	0.36	1.43	0.18	0.72
Prostate Stromal Cells, donor3	11405-118E1	118.25	3.75	0.10	0.31	0.21	0.10	0.10	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	191.98	1.46	0.36	0.36	0.00	0.36	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	103.07	4.51	0.00	0.07	0.07	0.07	0.07	0.21
Renal Epithelial Cells, donor1	11517-119H5	139.49	3.04	0.00	0.00	1.01	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	165.74	7.82	0.71	2.13	1.42	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	91.36	5.50	0.11	0.42	0.11	0.32	0.21	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	241.02	0.68	0.68	0.68	0.00	0.00	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	251.07	4.31	0.67	0.54	0.27	0.81	0.13	2.29
Renal Glomerular Endothelial Cells, donor3	11675-122H1	134.32	8.44	0.22	0.67	0.22	1.11	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	54.57	0.67	0.67	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	210.40	7.92	0.00	0.44	0.88	0.88	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	190.60	6.90	0.00	0.63	0.63	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	133.43	2.77	0.00	0.00	0.28	0.28	0.28	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	180.11	6.98	0.00	0.81	0.54	1.61	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	125.66	2.95	0.00	0.00	0.84	0.00	0.00	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	138.08	6.56	0.00	0.58	0.00	1.35	0.19	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	196.02	3.37	0.00	1.30	0.26	1.04	0.00	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	223.13	5.12	0.57	0.28	0.00	0.28	0.28	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	146.14	5.15	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	78.03	3.51	0.25	0.25	0.00	0.00	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.96	1.07	0.00	0.13	0.27	0.13	0.00	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	202.80	4.47	0.00	0.00	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	355.54	9.91	0.00	0.00	0.00	1.10	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	226.22	4.06	0.00	0.00	0.00	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	197.64	9.75	0.91	0.52	0.52	0.39	0.65	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	148.56	8.74	0.60	0.79	0.20	0.60	0.70	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	131.50	10.04	0.22	0.56	0.45	0.45	0.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	210.38	10.05	1.24	0.50	0.12	0.62	0.50	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	158.04	9.21	1.05	0.00	0.35	0.82	0.35	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	133.83	12.25	0.23	0.00	0.23	0.46	0.69	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	227.54	6.16	0.41	0.27	0.14	0.27	0.82	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	132.97	7.41	0.45	0.76	0.76	0.15	0.61	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	140.49	8.60	1.08	0.00	0.00	0.18	0.54	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	254.20	9.04	0.57	0.00	0.29	0.29	0.14	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	136.29	10.41	0.86	0.00	0.43	0.54	0.54	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	150.68	12.83	1.11	0.22	0.22	0.66	0.66	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	278.93	10.32	0.19	0.38	0.38	0.76	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	128.10	8.11	0.75	0.56	0.47	0.19	0.37	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	89.07	12.78	0.75	0.38	0.19	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	244.31	7.43	0.93	0.40	0.80	0.40	0.93	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	127.52	7.88	0.68	0.58	0.29	0.29	0.29	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	125.27	11.65	0.57	0.76	0.57	1.72	0.38	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	228.11	7.58	0.43	0.21	0.43	0.96	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	109.60	10.37	0.00	0.28	0.56	0.28	0.28	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	100.83	9.40	0.68	0.34	0.34	0.34	1.03	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	207.13	9.48	0.55	0.91	0.55	0.18	0.91	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	114.17	9.32	0.86	0.49	0.37	0.61	0.49	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	149.90	9.13	0.13	0.27	0.40	0.40	0.27	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	280.22	11.09	0.94	0.71	0.47	0.71	1.89	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	120.83	10.52	0.99	0.20	0.79	0.00	0.60	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	136.33	14.03	1.17	0.47	0.00	1.87	0.23	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	245.30	10.16	0.83	0.41	0.41	0.00	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	117.90	7.96	0.88	0.00	0.44	0.66	0.00	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	110.08	11.91	1.25	0.42	0.42	0.42	0.84	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	226.37	9.02	0.94	0.54	0.13	0.54	0.81	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	124.14	9.03	1.02	0.51	0.51	0.51	1.36	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	124.74	11.76	0.77	0.19	0.39	0.58	0.58	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	267.19	8.60	0.69	0.17	0.52	0.52	1.20	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	108.50	10.15	1.37	0.96	0.55	0.14	0.82	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	118.86	13.79	0.99	0.66	0.33	0.66	0.49	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	255.48	6.82	0.00	0.51	0.68	0.17	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	128.43	10.21	1.48	0.15	0.44	0.30	1.04	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	107.15	8.00	0.00	0.27	0.00	0.80	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	289.81	5.39	0.41	0.28	0.28	0.55	0.28	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	165.96	5.48	0.71	0.24	0.00	0.71	0.24	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	115.48	4.43	0.60	0.00	0.20	0.20	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	240.05	4.71	0.57	0.00	0.00	0.28	0.28	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	127.87	5.59	1.05	0.00	0.00	0.00	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	149.90	5.74	0.30	0.30	0.00	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	206.47	4.90	0.61	0.00	0.37	0.37	0.00	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	99.27	9.17	0.87	0.00	0.00	0.58	0.73	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	144.20	5.48	1.22	0.00	0.00	0.61	0.00	5.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	252.57	5.73	0.00	0.00	0.00	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	99.98	3.85	0.00	0.00	0.00	0.00	0.23	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	110.83	9.29	0.90	0.30	0.00	0.00	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	182.07	5.79	0.59	0.12	0.12	0.12	0.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	104.59	8.54	0.00	0.00	0.00	0.00	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	72.72	5.41	0.60	0.00	0.00	0.00	0.00	1.20
Schwann Cells, donor1	11498-119F4	358.65	5.27	0.38	0.19	0.38	0.94	0.00	2.26
Schwann Cells, donor2	11578-120F3	238.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	150.73	6.13	0.22	0.66	0.44	0.44	0.22	1.31
Sebocyte, donor1	11220-116B5	80.52	5.48	0.00	0.55	0.55	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	98.80	6.43	0.46	0.00	0.46	1.38	0.00	1.38
Sebocyte, donor3	11378-118B1	142.01	6.39	0.00	0.21	0.62	0.62	0.21	0.41
Sertoli Cells, donor1	11255-116F4	127.56	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	81.91	2.82	0.00	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	127.66	5.10	0.00	0.53	0.35	0.62	0.09	0.26
Skeletal Muscle Cells, donor2	11358-117H8	110.60	2.17	0.00	0.00	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	356.15	6.69	0.84	0.00	1.67	4.18	0.00	5.02
Skeletal Muscle Cells, donor4	11451-119A2	269.26	11.31	0.31	0.94	0.31	1.57	0.31	3.14
Skeletal Muscle Cells, donor5	11455-119A6	274.10	7.88	1.04	0.74	0.74	1.19	0.45	1.64
Skeletal Muscle Cells, donor6	11459-119B1	257.17	12.93	0.77	0.77	0.46	1.23	0.15	2.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	223.28	4.54	0.00	0.13	0.25	0.88	0.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	195.63	7.13	0.14	0.14	0.14	1.43	0.00	2.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	127.19	10.32	0.20	1.59	0.60	1.29	0.20	1.39
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	130.67	5.22	0.25	0.17	0.34	0.67	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	107.12	8.69	0.72	0.72	0.00	0.72	0.72	5.07
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	210.11	4.27	0.28	0.14	0.69	0.41	0.41	5.92
Skin - palm, donor1	10286-104F7	139.68	5.37	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	148.05	7.35	0.29	0.58	0.58	0.72	0.58	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	144.77	20.45	1.64	0.82	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	131.13	5.58	0.52	0.52	0.52	0.91	0.26	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	81.60	5.00	0.28	1.11	0.28	0.42	0.00	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	87.63	6.75	0.56	0.28	0.56	0.14	0.28	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	108.68	13.11	1.27	0.00	0.42	0.85	0.85	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	55.61	3.97	0.45	0.30	0.37	0.30	0.07	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	473.37	4.94	0.31	0.31	0.31	1.23	0.31	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	85.60	2.45	0.00	0.00	0.00	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	136.38	4.11	0.00	0.59	0.59	0.59	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	57.02	3.54	0.00	0.22	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	108.68	9.84	0.79	0.00	0.39	2.36	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	146.79	4.64	0.77	0.00	0.00	0.77	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	119.09	1.00	1.00	0.00	0.00	0.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	113.38	3.99	0.53	0.13	0.40	0.27	0.13	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	171.12	6.87	0.22	0.89	0.00	0.44	0.89	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	244.03	9.35	0.77	0.38	0.51	1.28	0.64	3.07
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	162.47	5.54	0.00	0.00	0.33	0.00	0.00	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	96.57	4.43	0.30	0.00	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	116.74	2.70	0.14	0.43	0.28	0.28	0.00	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	193.42	4.88	0.00	1.14	0.81	0.98	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	125.43	2.74	0.00	0.30	0.00	0.00	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	138.40	3.79	0.25	0.25	0.51	0.25	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	176.91	4.29	0.00	0.00	0.48	0.48	0.00	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	136.71	3.83	0.15	0.00	0.00	0.44	0.00	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	173.70	4.95	0.22	0.00	0.00	1.29	0.00	2.15
Smooth Muscle Cells - Colonic, donor3	11396-118D1	136.97	5.88	0.21	0.42	0.42	0.21	0.21	1.99
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	97.29	8.51	0.62	0.62	0.15	1.24	0.93	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	101.32	8.62	4.31	1.08	2.16	0.00	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	178.12	11.06	1.20	0.00	1.49	0.60	0.30	2.99
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	203.82	8.19	0.34	0.68	1.37	1.37	0.34	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	169.07	2.91	0.00	0.08	0.00	0.63	0.00	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	70.55	5.13	0.20	0.60	0.50	1.11	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	75.32	7.28	0.91	0.68	0.00	0.46	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	296.47	3.02	0.00	0.00	0.00	1.21	0.60	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	146.50	14.57	2.12	3.71	0.26	3.18	0.00	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	186.56	2.53	0.27	0.00	0.13	0.40	0.40	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	125.09	4.63	0.38	0.25	0.50	1.13	0.25	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	95.88	1.52	0.00	0.25	0.00	0.00	0.00	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	128.91	3.92	0.30	0.30	0.45	0.15	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	105.77	3.75	0.00	0.00	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	134.39	0.00	0.00	1.29	0.00	1.29	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	110.69	7.91	0.47	0.47	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	76.24	7.57	0.00	0.50	2.02	0.00	0.50	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	107.81	6.58	0.31	1.57	0.94	0.63	0.31	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	135.70	5.60	0.29	0.00	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	158.28	8.50	0.67	0.50	0.25	1.50	0.17	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	120.99	3.74	0.00	0.00	0.00	0.00	0.00	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	101.61	4.89	0.43	0.43	0.29	0.29	0.14	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	146.34	7.65	1.02	0.25	0.51	0.51	0.25	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	202.32	4.14	1.13	0.19	0.00	0.38	0.19	2.82
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	152.88	5.03	0.28	0.14	0.28	0.84	0.00	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	263.26	4.36	0.17	0.00	0.17	0.50	0.00	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	107.14	1.43	0.00	0.00	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	122.82	4.65	1.47	0.24	0.49	0.49	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	184.49	6.19	0.00	0.44	0.44	0.44	0.88	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	93.04	2.05	0.00	0.00	0.00	0.59	0.00	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	136.64	1.75	0.00	0.39	0.00	0.00	0.19	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	85.68	2.38	0.26	0.00	0.26	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	232.09	1.86	0.00	0.00	0.37	0.74	0.00	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	128.64	2.52	0.36	0.00	0.00	0.00	0.00	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	73.81	7.10	0.00	0.28	1.42	0.00	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	179.60	5.51	0.00	0.79	0.79	1.18	0.00	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	150.34	1.78	0.00	0.00	0.00	0.00	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	119.00	0.80	0.00	0.00	0.00	0.00	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	157.17	2.93	0.00	0.84	0.00	0.00	0.00	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	227.35	1.83	0.46	0.00	0.46	0.00	0.46	1.38
Synoviocyte, donor1	11291-117A4	81.97	6.90	0.00	0.00	0.17	0.00	0.17	0.50
Synoviocyte, donor2	11368-117I9	119.01	3.02	0.00	1.34	0.50	0.50	0.00	2.18
Synoviocyte, donor3	11440-118H9	231.90	1.79	0.00	0.22	0.22	0.22	0.00	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	186.17	10.72	1.07	0.71	1.07	0.36	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	103.07	3.96	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	114.85	4.86	0.69	0.69	0.00	0.00	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	77.63	5.95	0.22	0.22	0.22	1.36	0.00	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	127.95	7.34	0.00	0.77	1.16	1.93	0.39	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	155.76	7.44	0.00	1.15	0.57	0.57	0.00	4.58
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	78.74	0.98	0.00	0.00	0.12	0.00	0.00	0.37
Urethra, donor2	10319-105A4	59.35	1.80	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	167.90	4.25	0.53	0.27	0.27	1.33	0.00	0.80
Urothelial Cells, donor2	11600-120H7	157.42	2.80	0.00	0.40	0.00	0.80	0.00	1.20
Urothelial Cells, donor3	11681-122H7	146.00	3.44	0.00	0.00	0.23	0.23	0.00	2.98
Urothelial cells, donor0	11216-116B1	140.65	3.12	0.00	0.00	0.22	0.67	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	397.73	3.56	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	393.14	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	142.38	0.68	0.00	0.00	0.00	0.00	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	149.44	2.07	0.00	0.00	0.00	0.00	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	165.01	4.65	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	341.53	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	379.97	0.92	0.00	0.00	0.00	0.00	0.00	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	163.41	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	132.49	9.01	0.25	0.99	0.37	0.99	0.25	1.36
Wilms' tumor cell line:HFWT	10597-108E3	81.84	2.64	0.00	0.88	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	137.98	5.59	0.00	0.00	0.00	1.96	0.00	0.84
achilles tendon, donor2	10292-104G4	95.06	2.07	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	197.85	19.12	2.55	0.51	0.51	0.25	2.04	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	217.32	16.72	3.02	0.23	0.23	0.23	2.09	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	107.19	5.34	0.71	0.00	0.00	0.12	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	139.87	20.68	4.08	0.54	1.36	0.27	1.36	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	174.27	8.43	0.00	0.00	0.00	0.56	0.00	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	225.23	7.19	0.42	0.00	0.00	0.42	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	267.58	8.44	1.91	0.00	0.00	0.27	0.82	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	434.03	10.13	0.88	0.00	0.00	1.76	0.44	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	255.22	6.13	0.82	0.00	0.00	0.00	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	267.93	10.87	1.55	0.78	0.00	1.16	0.39	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	277.29	10.67	0.55	2.02	1.10	2.76	0.55	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	296.44	3.90	0.00	3.90	0.00	3.90	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	280.72	15.34	2.09	0.23	0.00	0.70	1.63	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	536.96	17.86	1.29	0.52	1.55	6.21	0.26	2.59
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	297.80	8.77	0.29	0.58	0.00	1.17	0.58	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	161.27	3.25	0.46	1.86	0.00	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	142.70	11.10	1.65	0.00	0.00	0.00	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	160.23	4.60	0.92	0.61	0.00	1.53	0.31	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	143.37	5.12	0.43	0.43	0.43	0.85	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	134.36	5.46	1.21	0.61	0.00	0.30	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	145.87	7.94	0.48	0.00	0.00	1.68	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	159.48	8.46	0.22	0.89	0.89	2.45	0.67	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	226.14	12.01	0.33	0.33	0.33	1.33	0.67	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	314.04	20.44	0.00	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	229.76	16.57	1.13	2.26	0.75	0.38	0.00	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	204.11	9.59	1.31	0.44	0.00	0.00	0.00	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	369.27	9.37	0.00	0.00	0.00	0.00	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	178.74	4.95	0.00	0.24	0.71	0.00	0.24	2.12
adipose tissue, adult, pool1	10010-101C1	50.88	0.62	0.00	0.00	0.00	0.16	0.00	0.31
adipose, donor1	10184-103D4	340.70	6.45	0.00	0.00	0.59	0.00	0.00	8.80
adipose, donor2	10185-103D5	98.54	3.24	0.00	0.00	0.00	0.41	0.00	2.03
adipose, donor3	10186-103D6	93.39	5.72	0.82	0.27	0.54	0.27	0.27	1.91
adipose, donor4	10187-103D7	109.21	19.07	0.00	1.73	0.00	4.33	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	132.88	6.47	0.16	0.16	0.47	0.47	0.32	0.63
adrenal gland, adult, pool1	10081-102A9	58.20	3.64	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	83.78	2.27	0.40	0.00	0.27	0.00	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	249.75	5.00	0.36	0.71	2.50	2.14	0.36	3.93
amniotic membrane cells, donor1	12235-129G3	86.25	3.48	0.70	0.00	0.23	0.00	0.00	0.70
amniotic membrane cells, donor2	12236-129G4	118.34	0.68	0.00	0.00	0.00	0.00	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	157.32	2.95	0.29	0.00	0.00	0.00	0.00	1.18
amygdala - adult, donor10196	10167-103B5	47.43	2.37	0.00	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	36.70	3.65	0.41	0.00	0.00	0.00	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	48.74	3.55	0.65	3.23	1.29	0.65	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	194.56	6.75	2.42	0.00	0.00	0.00	0.51	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	305.34	26.25	1.99	1.54	0.88	2.21	1.32	3.09
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	210.44	17.04	7.01	0.00	0.00	0.00	0.67	1.67
aorta, adult, pool1	10052-101G7	80.22	0.59	0.00	0.00	0.00	0.20	0.00	0.78
appendix, adult	10189-103D9	100.91	3.49	0.39	0.00	0.00	0.00	0.00	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	170.59	9.29	1.03	0.00	0.34	0.69	0.00	0.69
artery, adult	10190-103E1	122.28	1.36	0.00	0.00	0.00	0.00	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	167.90	6.23	0.87	0.14	0.14	0.00	0.00	0.72
b cell line:RPMI1788	10427-106D4	165.80	5.20	0.89	0.15	0.15	0.45	0.59	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	76.85	4.16	0.00	0.00	0.28	0.00	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	106.48	6.95	0.40	0.00	0.30	0.50	0.00	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	58.92	2.01	0.33	0.00	0.00	0.33	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	241.59	3.36	0.00	0.00	0.00	0.56	0.00	3.36
bladder, adult, pool1	10011-101C2	87.24	0.65	0.00	0.33	0.00	0.11	0.00	1.85
blood, adult, pool1	10053-101G8	150.59	0.00	0.00	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	83.07	3.43	0.00	0.00	0.00	0.86	0.00	0.86
bone marrow, adult	10192-103E3	46.56	2.02	0.00	0.00	0.00	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	64.58	2.05	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	46.21	3.12	0.11	0.00	0.00	0.22	0.22	0.45
brain, fetal, pool1	10085-102B4	195.01	2.67	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	257.35	6.28	0.99	0.33	0.33	0.00	0.33	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	91.62	3.37	0.00	0.12	0.12	0.00	0.12	0.25
breast, adult, donor1	10080-102A8	68.82	0.63	0.00	0.63	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	97.44	5.34	0.13	0.64	0.25	1.14	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	208.41	7.11	0.93	0.00	0.00	0.62	0.31	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	210.19	6.45	0.23	1.15	0.00	2.30	0.23	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	118.62	5.33	0.00	0.00	0.24	0.24	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	204.05	4.23	0.00	0.00	0.00	0.94	0.00	2.35
carcinoid cell line:NCI-H727	10735-110B6	177.31	5.47	0.44	0.00	0.11	0.33	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	251.93	5.07	0.00	0.32	0.32	1.58	0.00	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	241.69	7.45	0.00	0.27	0.27	0.80	0.27	4.79
caudate nucleus - adult, donor10196	10177-103C6	42.60	2.30	0.00	0.00	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	54.72	3.51	0.17	0.50	0.00	0.17	0.84	0.50
caudate nucleus, adult, donor10258	10379-105H1	77.94	2.29	0.00	0.00	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	66.65	3.66	0.37	0.73	1.10	1.46	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	37.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	35.87	2.78	0.00	0.00	0.21	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	68.64	1.72	0.00	0.34	0.00	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	78.05	2.49	0.00	0.83	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	92.79	4.29	0.50	0.00	0.00	0.00	0.00	0.76
cerebrospinal fluid, donor2	10294-104G6	57.74	2.92	0.00	0.00	0.00	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	117.90	5.75	0.00	0.14	0.00	0.86	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	164.56	8.78	1.99	0.50	0.00	0.33	0.83	0.17
cervix, adult, pool1	10013-101C4	106.88	1.57	0.00	0.00	0.00	0.00	0.00	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	91.96	4.60	0.14	0.14	0.28	0.28	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	103.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	216.86	11.18	0.62	0.50	0.00	1.37	0.25	0.75
choriocarcinoma cell line:SCH	10785-110H2	92.90	2.71	0.12	0.25	0.62	0.00	0.25	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	138.04	4.98	0.71	0.24	0.00	0.95	0.00	0.71
chorionic membrane cells, donor1	12238-129G6	93.17	2.85	0.28	0.00	0.00	0.00	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	90.98	3.28	0.20	0.30	0.10	0.20	0.00	0.50
chorionic membrane cells, donor3	12240-129G8	117.59	2.75	0.00	0.55	0.00	0.00	0.00	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	262.55	11.11	0.00	0.00	2.02	1.01	0.00	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	274.12	10.37	0.38	0.19	0.19	1.54	0.77	4.42
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	284.47	12.04	0.42	0.63	0.00	0.21	0.42	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	183.10	8.99	0.51	1.03	0.77	1.03	0.26	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	192.53	11.37	0.97	1.21	1.21	0.73	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	169.20	10.79	0.20	2.24	1.83	1.22	0.00	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	326.26	30.92	0.88	4.71	1.77	4.71	0.88	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	149.08	10.43	0.52	0.78	0.52	0.78	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	83.66	3.43	0.23	0.23	0.00	0.23	0.23	1.37
clear cell carcinoma cell line:TEN	10636-108I6	158.41	7.81	0.87	0.17	0.00	0.69	0.52	2.08
colon carcinoma cell line:CACO-2	10513-107D9	80.54	5.49	1.28	0.18	0.18	0.73	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	287.72	4.56	0.38	0.00	0.00	3.04	0.76	0.76
colon, adult, donor1	10082-102B1	102.34	4.76	0.00	0.00	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	92.48	2.59	0.00	0.00	0.12	0.12	0.00	0.24
colon, fetal, donor1	10070-101I7	79.72	0.62	0.00	0.00	0.00	0.00	0.00	1.85
common myeloid progenitor CMP, donor1	12130-128D6	187.92	22.92	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	525.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	92.21	8.50	2.12	0.00	0.00	0.85	0.42	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	123.91	9.36	0.15	0.30	0.15	1.81	0.15	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	151.87	8.18	1.13	0.28	0.71	2.12	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	44.22	1.22	0.00	0.00	0.11	0.11	0.11	0.33
cruciate ligament, donor2	10295-104G7	75.37	0.00	0.00	0.00	0.00	0.00	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	68.22	0.00	0.00	0.00	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	61.20	3.36	0.00	0.00	0.00	0.00	0.24	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	287.47	13.32	0.92	0.23	0.23	0.69	0.92	5.74
ductal cell carcinoma cell line:KLM-1	10438-106E6	154.12	10.26	1.54	0.00	0.26	0.77	1.03	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	112.42	7.46	0.48	0.24	0.24	0.72	0.00	1.20
ductus deferens, adult	10196-103E7	86.71	3.49	0.00	0.00	0.00	0.00	0.00	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	76.33	1.44	0.00	0.00	1.44	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	166.26	2.21	0.74	0.00	0.00	0.00	0.00	2.94
dura mater, adult, donor1	10041-101F5	77.47	1.90	0.08	0.00	0.08	0.08	0.00	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	73.95	101.04	15.10	4.22	6.00	3.33	7.11	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	150.60	29.38	1.86	1.86	1.86	2.44	1.43	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	172.04	5.55	0.00	1.23	0.00	1.23	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	147.72	2.42	0.00	1.82	0.61	0.00	0.61	2.72
embryonic pancreas cell line:1C3IKEI	10606-108F3	166.11	8.03	0.00	0.62	1.85	0.31	0.31	2.16
embryonic pancreas cell line:2C6	10603-108E9	273.20	5.25	0.00	1.31	2.63	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	56.65	10.73	0.67	1.34	0.34	0.00	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	105.12	4.17	0.00	0.18	0.00	0.72	0.72	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	112.89	9.81	1.93	0.48	0.32	1.13	0.32	2.09
epidermoid carcinoma cell line:A431	10426-106D3	124.94	6.56	1.67	0.33	0.33	0.11	0.44	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	134.29	7.15	1.32	1.21	0.33	0.77	0.55	0.11
epididymis, adult	10197-103E8	70.33	2.51	0.00	0.00	0.00	0.21	0.00	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	102.01	2.84	0.00	0.71	0.71	0.18	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	151.40	5.90	0.39	0.39	0.39	0.79	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	168.14	16.38	1.44	4.06	2.36	2.36	0.79	3.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	149.70	10.73	1.28	1.48	1.28	2.46	0.49	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	163.68	15.12	2.35	4.15	2.24	4.15	1.01	3.25
esophagus, adult, pool1	10015-101C6	105.01	1.27	0.11	0.11	0.00	0.00	0.00	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	158.92	2.13	0.13	0.50	0.50	0.38	0.13	0.38
eye - muscle inferior rectus, donor1	10272-104E2	55.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	2.10	0.00	0.00	0.00	0.00	0.00	4.21
eye - muscle medial, donor2	10299-104H2	62.51	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	81.40	3.44	0.00	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	87.44	2.91	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	88.22	0.76	0.00	0.25	0.00	0.00	0.00	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	135.15	6.03	1.15	0.51	0.13	1.67	0.51	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	137.94	14.48	0.47	0.24	0.47	1.42	1.42	0.47
frontal lobe, adult, pool1	10040-101F4	37.25	4.32	0.00	0.00	0.09	0.19	0.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	59.45	7.21	0.30	0.30	0.30	0.00	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	80.65	3.02	0.27	0.09	0.09	0.09	0.00	0.00
gall bladder, adult	10198-103E9	92.47	1.69	0.00	0.00	0.00	0.00	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	442.37	5.37	0.00	0.00	0.00	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	287.96	5.23	0.37	0.00	0.00	0.00	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	95.47	5.91	0.42	0.42	0.42	0.84	0.21	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	306.76	5.22	0.58	0.19	0.00	0.77	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	141.99	13.44	1.31	0.98	0.98	0.98	0.49	0.82
gastric cancer cell line:GSS	10560-108A2	97.93	2.75	0.00	0.00	0.00	0.92	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	126.11	8.68	1.14	0.00	0.23	0.00	0.00	1.14
giant cell carcinoma cell line:LU65	10487-107B1	177.50	6.65	0.69	0.69	1.38	1.84	0.00	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	169.63	4.34	0.84	0.14	0.28	0.84	0.00	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	152.64	9.73	2.00	0.25	0.00	1.00	0.25	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	78.85	4.54	0.63	0.32	0.11	0.63	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	63.62	5.62	0.70	0.42	0.14	0.56	0.28	0.28
glioblastoma cell line:T98G	10485-107A8	70.53	3.31	0.22	0.11	0.22	0.33	0.22	0.22
glioma cell line:GI-1	10413-106B8	79.96	2.34	0.29	0.00	0.00	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	60.50	1.46	0.00	0.00	0.00	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	36.86	2.20	0.00	0.24	0.00	0.00	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	98.58	1.37	1.37	0.00	0.00	0.00	0.00	4.11
globus pallidus, newborn, donor10223	10364-105F4	50.63	2.66	0.53	0.53	0.00	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	141.93	24.47	7.34	0.00	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	284.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	606.28	15.68	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	70.40	2.24	0.00	0.00	0.32	0.00	0.00	0.96
hIPS +CCl2, biol_rep1	14383-156B9	313.12	22.96	0.92	1.84	1.84	1.84	0.46	1.84
hIPS +CCl2, biol_rep2	14384-156C1	334.72	19.21	0.91	1.83	3.20	3.20	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	312.38	27.05	0.64	1.29	1.29	3.22	0.00	0.64
hIPS, biol_rep1	14380-156B6	165.29	43.12	0.00	0.00	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	249.66	34.98	0.69	2.06	4.12	2.74	1.37	3.43
hIPS, biol_rep3	14382-156B8	124.69	4.41	3.31	1.10	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	210.34	7.18	1.15	0.57	0.29	0.86	0.57	0.86
heart - mitral valve, adult	10205-103F7	66.07	1.79	0.30	0.00	0.00	0.00	0.00	0.90
heart - pulmonic valve, adult	10206-103F8	58.31	1.05	0.00	0.26	0.00	0.00	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	64.11	0.00	0.83	0.00	0.00	0.00	0.83	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	47.75	2.86	0.00	0.82	1.02	0.00	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	39.60	0.43	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	43.47	0.46	0.00	0.00	0.00	0.00	0.23	0.69
heart, fetal, pool1	10046-101G1	90.36	0.92	0.00	0.00	0.00	0.00	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	119.40	1.85	0.00	0.31	0.00	0.00	0.00	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	209.30	4.76	1.19	0.00	0.00	2.38	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	76.02	10.39	0.66	1.66	1.10	0.66	0.55	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	76.22	11.89	0.49	0.85	1.21	0.24	0.61	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	69.42	9.90	0.61	1.41	1.01	0.40	0.51	1.11
hepatoma cell line:Li-7	10484-107A7	34.03	4.78	0.56	0.44	0.22	0.00	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	155.07	9.25	1.91	1.41	1.11	0.90	1.11	0.80
hippocampus - adult, donor10196	10169-103B7	41.64	1.89	0.00	0.00	0.00	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	32.45	3.47	0.20	0.20	0.00	0.00	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	89.13	4.48	0.00	0.00	0.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	47.23	1.76	0.00	0.00	0.00	0.00	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	479.12	39.67	3.66	2.44	1.22	3.66	1.22	9.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	221.88	22.97	0.79	1.77	1.37	1.57	0.98	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	303.41	30.47	1.78	3.55	0.51	2.79	0.76	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	288.13	5.64	0.00	0.56	0.00	0.56	0.00	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	307.01	6.97	0.26	1.03	0.00	0.52	0.00	8.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	429.72	5.69	0.00	0.00	0.76	0.76	0.38	6.07
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	197.36	6.42	0.00	0.00	0.00	0.29	0.29	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	153.17	6.03	0.00	0.22	0.00	0.22	0.00	3.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	155.99	4.59	0.00	1.25	0.42	0.42	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	206.96	12.08	0.47	0.47	0.00	0.00	0.00	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	149.47	9.96	0.48	0.48	0.32	0.16	1.29	2.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	187.18	16.83	0.67	0.00	0.00	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	193.57	25.82	0.78	2.66	1.25	2.35	0.94	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	264.32	20.63	0.98	2.95	2.46	2.46	0.00	8.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	456.45	38.40	0.00	0.87	0.00	3.49	1.75	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	207.90	7.64	0.00	0.57	0.57	0.57	0.00	2.10
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	250.31	4.80	0.00	0.00	0.00	0.00	0.00	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	268.37	5.50	0.00	0.00	0.50	0.50	0.00	8.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	135.64	1.51	0.00	0.38	0.38	0.19	0.00	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	181.43	0.91	0.00	0.00	0.00	0.00	0.00	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	189.82	5.33	0.00	0.00	0.31	0.00	0.31	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	132.27	5.88	0.00	0.00	0.16	0.49	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	150.38	7.84	0.00	0.58	0.29	0.58	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	139.90	7.47	0.30	0.00	0.60	0.30	0.30	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	183.64	26.79	1.29	2.40	1.48	3.33	0.55	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	195.99	29.67	0.86	1.71	1.43	3.42	0.86	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	351.96	40.42	2.86	2.86	2.04	4.08	1.63	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	247.86	6.34	0.00	0.00	0.00	0.35	0.00	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	169.14	6.97	0.00	0.32	0.32	0.63	0.63	6.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	230.60	8.47	0.30	0.61	0.61	0.30	0.00	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	135.49	5.69	0.00	0.00	0.52	0.00	0.00	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	154.09	3.98	0.00	0.00	0.66	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	151.10	5.13	0.00	0.00	0.26	0.51	0.00	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	143.16	8.44	0.26	0.51	0.51	1.02	0.51	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	143.87	11.36	0.00	0.00	0.00	0.76	0.00	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	142.15	8.74	0.34	0.34	1.01	0.67	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	230.64	28.98	1.93	2.90	0.24	2.90	0.72	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	340.04	37.44	3.12	2.67	2.67	3.12	1.34	5.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	237.56	36.59	1.46	4.88	2.44	3.90	0.98	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	210.57	5.81	0.31	0.61	0.92	0.61	0.31	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	936.93	3.25	0.00	0.00	0.00	0.00	0.00	16.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	405.74	6.62	0.00	0.99	0.00	0.99	0.00	6.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	176.78	5.47	0.00	0.00	0.00	1.09	0.00	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	192.88	3.98	0.00	0.00	0.36	0.00	0.00	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	211.03	4.63	0.00	0.00	0.00	0.36	0.00	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	119.34	14.32	0.00	1.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	153.84	7.99	0.27	0.14	0.14	0.54	0.00	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	147.09	10.51	0.27	0.27	0.27	0.00	0.00	1.89
immature langerhans cells, donor1	11904-125F5	162.00	2.66	0.24	0.00	0.00	0.00	0.00	0.73
immature langerhans cells, donor2	11905-125F6	194.07	5.54	0.79	0.00	0.00	0.00	0.00	3.17
insula, adult, pool1	10039-101F3	43.44	5.58	0.09	0.00	0.28	0.38	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	238.33	7.15	0.65	1.30	0.00	1.30	0.33	3.58
kidney, adult, pool1	10017-101C8	48.26	1.70	0.10	0.10	0.20	0.10	0.00	0.10
kidney, fetal, pool1	10045-101F9	97.40	1.63	0.14	0.00	0.00	0.00	0.07	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	188.04	18.04	1.85	1.28	0.71	0.28	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	269.30	3.32	0.28	0.14	0.28	0.28	0.00	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	200.01	6.24	0.00	0.55	0.18	0.73	0.73	0.55
left atrium, adult, donor1	10079-102A7	52.31	1.09	0.00	0.00	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	47.53	0.51	0.00	0.00	0.51	0.00	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	203.84	9.03	1.37	0.27	1.09	1.64	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	80.11	4.67	0.36	0.00	0.36	0.72	0.72	3.59
leiomyoma cell line:15242A	10570-108B3	63.59	2.72	0.00	0.00	0.00	0.54	0.54	1.63
leiomyoma cell line:15425	10571-108B4	74.79	3.64	0.00	0.97	0.00	0.73	0.49	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	76.33	3.14	0.00	1.05	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	346.38	18.06	1.89	0.47	0.35	0.83	0.94	0.94
liposarcoma cell line:KMLS-1	10782-110G8	75.14	1.41	0.31	0.00	0.16	0.47	0.00	0.47
liposarcoma cell line:SW 872	10726-110A6	116.72	4.02	0.12	0.37	0.73	0.37	0.12	1.10
liver, adult, pool1	10018-101C9	55.26	1.94	0.00	0.32	0.16	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	51.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	38.21	3.21	0.00	0.15	0.00	0.15	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	34.33	4.06	0.18	0.18	0.00	0.18	0.18	0.37
locus coeruleus, adult, donor10258	10375-105G6	48.81	2.82	0.56	0.00	0.00	0.28	0.00	0.85
locus coeruleus, newborn, donor10223	10362-105F2	74.45	5.47	0.84	0.42	0.42	0.84	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	56.74	2.21	0.28	0.00	0.14	0.00	0.42	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	155.12	0.69	0.00	0.00	0.69	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	100.97	4.22	0.13	0.00	0.00	0.13	0.26	0.66
lung, adult, pool1	10019-101D1	71.11	0.59	0.00	0.12	0.00	0.24	0.00	0.35
lung, fetal, donor1	10068-101I5	190.37	1.14	0.00	0.00	0.00	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	64.61	2.29	0.00	0.00	0.46	0.46	0.00	1.37
lymph node, adult, donor1	10077-102A5	159.05	1.42	0.00	0.47	0.47	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	238.90	3.29	0.44	0.00	0.00	0.00	0.22	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	107.76	5.89	1.06	0.15	0.15	0.45	0.30	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	60.31	18.69	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	39.96	2.66	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	44.00	0.83	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	40.06	0.47	0.00	0.00	0.24	0.24	0.00	0.24
mature adipocyte, donor4	12234-129G2	51.59	0.26	0.00	0.00	0.00	0.26	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	163.45	8.34	0.48	0.24	0.24	0.95	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	36.10	3.38	1.13	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	37.52	5.33	0.00	0.37	0.00	0.00	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	71.16	6.99	0.00	0.00	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	108.75	2.56	0.00	0.00	0.00	0.43	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	50.79	4.89	0.17	0.00	0.00	0.17	0.17	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	27.16	4.88	0.00	0.21	0.00	0.00	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	5.78	0.00	0.00	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	60.30	5.74	1.44	0.72	0.36	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	60.35	0.65	0.00	0.65	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	30.50	1.70	0.00	0.15	0.00	0.00	0.00	0.77
medulla oblongata, adult, pool1	10038-101F2	37.06	2.69	0.16	0.00	0.08	0.00	0.08	0.00
medulla oblongata, newborn, donor10223	10361-105F1	59.37	2.43	0.00	0.00	0.69	0.00	0.00	1.04
medulloblastoma cell line:D283 Med	10838-111E1	404.08	17.05	1.11	0.22	0.22	1.99	0.89	2.44
medulloblastoma cell line:ONS-76	10759-110E3	97.08	5.50	0.49	0.49	0.49	0.49	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	57.93	9.92	0.72	0.00	0.00	0.29	0.57	0.29
melanoma cell line:G-361	10465-106H6	200.88	5.70	1.36	0.27	0.27	4.07	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	106.73	2.71	0.36	0.00	0.00	0.00	0.00	2.71
merkel cell carcinoma cell line:MKL-1	10843-111E6	156.85	8.81	0.88	0.00	0.00	0.88	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	135.06	24.37	0.52	0.26	0.52	0.00	0.26	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	206.52	7.21	0.61	0.15	0.00	0.61	0.46	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	190.51	2.91	0.18	0.00	0.00	0.18	0.00	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	117.61	5.38	0.41	0.41	0.00	1.24	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	185.57	2.11	0.00	0.00	0.00	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	205.66	3.47	0.19	0.00	0.00	0.00	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	90.92	2.08	0.69	0.00	0.00	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	203.22	1.72	0.51	0.17	0.00	0.00	0.00	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	184.60	2.99	0.12	0.00	0.00	0.00	0.23	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	159.70	5.17	0.40	0.27	0.53	0.40	0.13	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	148.27	6.35	0.68	0.54	0.54	0.68	0.14	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	118.50	3.84	0.43	0.28	0.14	0.71	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	133.39	5.27	0.33	0.00	0.00	0.00	0.00	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	135.74	4.43	0.00	0.14	0.00	0.14	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	97.39	4.89	0.00	0.00	0.00	0.70	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	195.18	2.86	0.00	0.00	0.20	0.00	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	88.07	2.88	0.00	0.00	0.00	0.00	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	134.38	2.07	0.00	0.10	0.10	0.00	0.10	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	59.28	4.33	0.00	0.46	0.23	0.23	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	106.99	8.81	0.42	0.42	0.00	1.26	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	150.48	3.74	0.30	0.15	0.30	0.00	0.30	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	147.14	2.10	0.00	0.44	0.09	0.26	0.00	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	114.87	3.68	0.00	0.37	0.00	0.00	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	75.83	3.43	0.29	0.57	0.00	0.29	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	95.99	12.21	1.26	0.84	0.42	0.84	0.42	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	146.13	2.28	0.00	0.00	0.00	0.00	0.00	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	125.85	3.07	0.00	0.00	0.00	0.51	0.00	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	128.78	3.66	0.26	0.26	0.26	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	117.38	1.85	0.00	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	119.80	3.29	0.24	0.00	0.00	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	119.48	4.06	0.00	0.34	0.34	0.00	0.00	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	119.46	1.57	0.00	0.00	0.79	0.00	0.00	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	99.63	1.39	0.00	0.00	0.00	0.46	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	148.25	3.17	0.00	0.00	0.00	0.00	0.00	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	125.16	2.23	0.22	0.22	0.22	0.00	0.00	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	119.70	2.88	0.00	0.00	0.24	0.24	0.00	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	118.80	2.20	0.00	0.00	0.00	0.00	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	109.42	2.69	0.00	0.00	0.34	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	106.03	2.05	0.41	0.00	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	103.95	3.01	0.00	0.43	0.43	0.43	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	155.86	5.47	0.00	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	134.29	0.00	0.00	0.00	0.00	0.00	0.00	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	179.93	1.95	0.32	0.00	0.32	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	141.13	2.91	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	162.06	4.26	0.00	0.00	0.00	1.07	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	152.92	2.45	0.00	0.00	0.00	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	148.88	3.89	0.00	0.00	0.00	0.00	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	119.63	0.00	0.00	0.00	0.00	2.10	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	142.07	4.97	0.99	0.00	0.00	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	181.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	144.68	3.56	0.00	0.59	0.00	0.59	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	155.96	2.44	0.00	0.00	0.00	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	162.78	1.90	0.00	0.63	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	175.56	2.76	0.00	0.00	0.69	0.00	0.00	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	141.85	4.30	2.15	2.15	0.00	0.00	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	139.71	7.98	0.00	0.00	0.00	0.00	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	199.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	195.99	2.85	0.00	0.00	0.00	0.00	0.00	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	235.95	7.15	0.00	0.00	1.59	0.00	0.00	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	201.03	6.48	0.00	0.59	0.00	0.00	0.00	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	180.17	3.43	0.00	0.00	0.00	0.00	0.00	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	180.45	4.01	0.00	0.00	0.00	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	153.75	1.18	0.00	0.00	0.00	0.00	0.00	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	190.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	193.44	6.88	0.00	0.00	0.69	0.69	0.00	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	152.90	2.47	0.00	0.99	0.00	0.00	0.00	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	122.24	0.00	0.00	0.00	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	142.48	1.27	0.00	0.00	0.00	0.00	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	62.06	1.21	0.00	0.81	0.40	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	80.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	78.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	68.58	1.82	0.00	0.00	0.61	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	59.30	0.00	0.00	0.82	0.00	0.00	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	119.85	3.97	0.00	0.00	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	132.72	0.65	0.00	0.00	0.32	0.32	0.00	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	142.61	2.04	0.00	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	69.63	0.77	0.00	0.00	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	87.17	4.25	0.24	0.24	0.24	0.24	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	57.92	3.71	2.32	0.23	0.23	0.23	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	162.40	12.82	0.00	0.00	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	93.50	11.92	0.92	0.72	0.62	0.72	0.41	0.41
mesothelioma cell line:Mero-25	10850-111F4	139.58	12.94	0.91	0.68	1.13	1.13	0.23	0.68
mesothelioma cell line:Mero-41	10851-111F5	148.40	3.91	0.00	0.00	0.00	0.98	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	120.46	9.08	0.00	0.22	0.22	0.89	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	90.41	9.99	1.31	0.53	0.00	0.00	0.53	0.26
mesothelioma cell line:Mero-83	10854-111F8	118.81	8.17	0.17	0.85	1.19	1.19	0.68	0.34
mesothelioma cell line:Mero-84	10855-111F9	96.05	3.54	0.00	0.00	0.25	0.25	0.76	0.51
mesothelioma cell line:Mero-95	10856-111G1	98.97	6.21	0.21	0.41	0.21	0.62	0.21	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	120.76	5.47	0.17	0.33	0.17	1.49	0.33	0.33
mesothelioma cell line:NCI-H226	10846-111E9	150.40	15.38	2.17	1.09	1.09	0.36	0.72	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	138.88	2.56	0.00	0.34	0.68	1.20	0.17	0.34
mesothelioma cell line:NCI-H28	10845-111E8	203.32	6.11	0.25	0.51	0.51	0.76	0.00	3.05
mesothelioma cell line:No36	10857-111G2	88.40	6.20	0.00	0.65	0.00	1.30	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	99.71	6.77	0.27	0.00	0.00	0.81	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	108.63	0.38	0.00	0.19	0.38	0.00	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	61.67	1.10	0.00	0.24	0.24	0.00	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	143.23	0.72	0.00	0.36	0.00	0.00	0.00	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	42.12	6.20	0.98	0.33	0.65	0.00	0.33	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	89.44	8.48	0.21	1.27	0.00	0.64	0.42	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	112.88	7.60	0.46	0.00	0.23	0.69	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	162.70	5.14	0.95	0.19	0.00	0.57	0.38	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	188.49	4.99	0.18	0.18	0.00	1.48	0.18	0.55
myeloma cell line:PCM6	10474-106I6	131.84	4.55	0.20	0.00	0.20	0.40	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	87.76	4.57	1.01	0.00	0.00	0.51	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	117.49	4.12	0.20	0.00	0.39	0.39	0.20	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	118.78	2.45	0.33	0.56	0.11	0.22	0.56	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	118.03	4.71	0.00	0.22	0.29	0.66	0.37	0.74
nasal epithelial cells, donor2	12227-129F4	82.25	4.42	0.55	0.55	0.00	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	283.43	5.75	0.23	0.00	0.46	0.46	0.23	0.46
neuroblastoma cell line:NB-1	10539-107G8	128.34	8.42	0.94	0.19	0.00	0.00	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	115.57	13.29	1.05	0.21	0.00	0.63	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	744.47	10.25	0.93	0.19	0.00	0.56	0.37	2.24
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	158.70	4.03	0.95	0.47	0.71	0.24	0.00	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	168.36	5.23	0.16	0.00	0.00	0.79	0.32	2.69
neuroectodermal tumor cell line:TASK1	10774-110F9	283.57	4.03	0.20	0.20	0.00	0.60	0.00	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	190.09	9.54	0.00	0.00	0.00	1.27	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	111.26	3.99	0.27	0.27	0.53	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	246.24	14.21	2.54	0.00	0.00	0.00	1.01	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	102.46	8.01	0.00	0.00	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	126.00	3.85	0.00	1.28	0.00	0.32	0.32	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	65.69	3.15	0.00	0.00	0.00	0.00	0.26	0.79
nucleus accumbens, adult, pool1	10037-101F1	48.65	4.41	0.09	0.00	0.09	0.00	0.28	0.00
occipital cortex - adult, donor10196	10172-103C1	37.09	2.06	0.00	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	27.91	4.56	0.27	0.00	0.00	0.00	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	57.14	3.64	0.00	0.36	0.36	1.09	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	26.76	4.46	0.00	0.00	0.00	0.00	0.00	0.79
occipital lobe, fetal, donor1	10073-102A1	115.86	2.57	0.00	0.43	0.00	0.00	0.00	1.72
occipital pole, adult, pool1	10036-101E9	41.47	4.18	0.16	0.00	0.00	0.08	0.08	0.08
olfactory region, adult	10195-103E6	54.26	2.48	0.00	0.19	0.00	0.19	0.38	0.00
optic nerve, donor1	10277-104E7	88.05	2.00	0.00	0.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	188.86	12.30	2.73	1.14	1.03	0.57	0.68	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	198.80	8.79	0.96	1.10	0.82	1.10	0.14	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	119.71	8.80	0.51	0.34	0.00	0.51	0.17	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	335.55	15.71	1.27	0.12	0.12	0.81	0.81	1.50
osteoclastoma cell line:Hs 706.T	10704-109H2	71.73	2.94	0.00	0.00	0.59	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	266.29	4.67	1.87	0.00	0.00	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	109.00	6.15	0.64	0.21	0.42	0.42	0.42	0.42
ovary, adult, pool1	10020-101D2	123.78	1.14	0.00	0.00	0.09	0.17	0.00	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	74.06	3.67	0.37	0.00	0.00	0.18	0.00	0.73
pancreas, adult, donor1	10049-101G4	221.99	4.70	0.00	0.00	0.94	0.00	0.00	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	138.37	3.35	0.00	0.56	0.28	1.12	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	115.50	7.15	0.85	0.34	0.17	0.68	0.51	2.38
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	100.67	1.82	0.50	0.17	0.17	0.33	0.17	0.50
paracentral gyrus, adult, pool1	10035-101E8	42.37	4.03	0.00	0.09	0.09	0.00	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	79.27	8.07	0.00	1.47	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	48.91	1.88	0.94	0.00	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	34.20	4.85	0.00	0.00	0.00	0.00	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	42.12	3.97	0.09	0.00	0.00	0.00	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	170.69	2.91	0.00	0.00	0.97	0.00	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	65.43	6.73	0.00	1.12	0.37	0.00	0.75	0.00
parotid gland, adult	10199-103F1	210.28	3.70	0.62	0.00	0.00	0.00	0.62	0.62
penis, adult	10200-103F2	99.37	1.61	0.00	0.00	0.00	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	168.64	1.30	0.00	0.00	0.00	0.19	0.00	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	104.32	3.35	0.58	0.29	0.15	0.15	0.00	1.02
pineal gland - adult, donor10196	10179-103C8	56.12	1.94	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	45.60	2.37	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	77.13	0.63	0.00	0.00	0.00	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	130.52	4.05	0.00	0.00	0.00	0.00	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	89.64	1.56	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	200.04	9.36	0.85	0.00	0.00	0.00	0.00	2.55
placenta, adult, pool1	10021-101D3	47.09	0.75	0.22	0.11	0.00	0.00	0.11	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	307.23	19.07	3.97	1.32	0.53	2.78	1.59	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	46.07	0.93	0.00	0.00	0.00	0.00	0.16	0.31
pons, adult, pool1	10033-101E6	31.41	3.27	0.26	0.09	0.09	0.00	0.00	0.00
postcentral gyrus, adult, pool1	10032-101E5	48.38	4.01	0.35	0.17	0.00	0.00	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	75.29	18.82	2.09	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	302.94	0.00	0.00	0.00	5.51	0.00	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	539.84	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	120.90	13.55	0.87	1.31	1.02	1.17	0.00	0.44
prostate cancer cell line:PC-3	10439-106E7	73.87	3.81	0.18	0.73	0.36	0.00	0.18	0.18
prostate, adult, pool1	10022-101D4	117.26	0.36	0.00	0.18	0.00	0.09	0.00	0.54
putamen, adult, donor10196	10176-103C5	53.82	3.54	0.47	0.00	0.00	0.00	0.24	0.47
putamen, adult, donor10252	10152-102I8	60.78	1.96	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	140.97	5.46	0.00	2.19	0.00	1.09	1.09	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	88.43	1.69	0.48	0.00	0.00	0.00	0.48	0.24
putamen, newborn, donor10223	10365-105F5	102.70	6.00	0.00	0.00	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	134.70	3.78	0.58	0.29	0.29	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	125.19	2.78	0.00	0.00	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	46.22	2.12	0.42	0.00	0.00	0.00	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	63.79	0.83	0.00	0.00	0.41	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	73.26	1.59	0.00	0.00	0.00	0.00	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	270.97	7.53	0.00	0.00	0.00	0.52	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	117.91	11.07	0.49	0.37	0.74	0.86	0.49	2.21
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	237.05	14.06	0.28	0.56	0.28	1.12	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	272.83	3.79	0.00	0.00	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	218.02	2.75	0.81	0.16	0.32	0.65	0.16	1.29
salivary acinar cells, donor2	11772-123I8	229.25	1.65	0.14	0.00	0.14	0.28	0.00	1.65
salivary acinar cells, donor3	11773-123I9	209.87	2.65	0.00	0.66	0.00	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	335.16	1.14	0.00	0.00	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	106.82	2.87	0.08	0.08	0.25	0.17	0.17	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	96.63	2.47	0.00	0.12	0.47	0.35	0.12	0.71
seminal vesicle, adult	10201-103F3	91.53	2.65	0.00	0.00	0.00	0.00	0.00	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	107.13	8.26	0.97	0.24	0.00	0.97	0.24	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	87.57	2.01	0.00	0.25	0.00	0.00	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	90.32	3.01	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	125.19	4.03	0.40	0.00	0.13	0.13	0.27	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	73.61	2.43	0.22	0.22	0.11	0.22	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	215.86	8.77	0.90	0.39	0.26	2.06	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	105.69	0.00	0.00	0.00	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	78.56	0.72	0.00	0.00	0.00	0.36	0.00	0.48
skeletal muscle, fetal, donor1	10066-101I3	134.67	0.00	0.00	0.00	0.00	1.01	0.00	4.02
skin, adult, donor1	10074-102A2	81.42	0.00	0.00	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	61.23	2.52	0.00	1.26	0.00	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	217.79	13.01	0.67	1.00	0.67	0.00	1.00	7.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	154.77	11.35	2.21	0.00	0.00	0.00	0.95	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	240.55	6.36	0.39	0.00	0.58	1.54	0.00	1.93
small cell lung carcinoma cell line:LK-2	10541-107H1	204.72	10.05	1.98	0.00	0.00	0.99	0.66	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	323.47	2.41	0.00	0.16	0.00	1.45	0.00	1.29
small cell lung carcinoma cell line:WA-hT	10562-108A4	120.51	10.90	1.09	0.44	0.22	0.00	0.22	0.87
small intestine, adult, pool1	10024-101D6	62.47	2.15	0.00	0.00	0.00	0.00	0.00	0.48
small intestine, fetal, donor1	10064-101I1	61.42	1.47	0.49	0.49	0.49	0.00	0.00	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	97.45	4.62	0.51	0.00	0.00	0.00	1.03	4.62
smooth muscle, adult, pool1	10048-101G3	99.25	0.78	0.26	0.00	0.00	0.00	0.00	0.78
somatostatinoma cell line:QGP-1	10781-110G7	199.94	4.29	0.27	0.00	0.00	0.00	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	44.05	2.75	0.23	0.00	0.00	0.00	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	32.33	0.79	0.00	0.39	0.00	0.39	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	178.48	2.77	0.00	0.00	0.00	0.69	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	59.15	3.05	1.22	0.00	0.00	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	78.98	1.38	0.46	0.46	0.00	0.00	0.92	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	116.50	2.99	0.45	0.15	0.00	0.00	0.30	0.75
spleen, adult, pool1	10025-101D7	80.40	1.54	0.00	0.11	0.11	0.22	0.11	0.11
spleen, fetal, pool1	10044-101F8	99.00	1.75	0.00	0.40	0.08	0.08	0.00	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	92.85	2.59	0.52	0.00	0.52	0.41	0.41	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	128.74	6.65	1.14	0.76	0.76	0.95	0.76	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	47.87	6.64	0.70	1.05	1.05	0.35	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	232.60	13.68	1.56	0.00	0.00	2.35	0.78	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	101.19	6.30	0.23	0.00	0.23	0.79	0.00	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	89.80	8.47	0.00	0.85	0.00	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	159.50	6.77	0.42	0.42	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	91.85	2.14	1.07	0.00	0.00	0.00	0.00	2.14
submaxillary gland, adult	10202-103F4	167.49	3.99	0.00	0.00	0.00	0.00	0.00	2.85
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	34.48	1.87	0.21	0.00	0.00	0.21	0.00	0.62
substantia nigra, adult, donor10258	10371-105G2	112.24	6.72	0.00	0.00	0.00	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	41.69	0.71	0.00	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	89.64	7.34	0.23	0.46	0.23	0.92	0.00	0.92
temporal lobe, adult, pool1	10031-101E4	49.42	3.98	0.08	0.00	0.08	0.17	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	87.61	4.99	1.42	0.00	0.00	0.00	0.00	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	132.74	4.40	0.00	0.00	0.00	0.88	0.00	2.20
tenocyte, donor1	11763-123H8	142.78	2.79	0.70	0.35	0.00	0.35	0.00	1.05
tenocyte, donor2	11765-123I1	149.17	2.29	0.00	0.00	0.38	0.00	0.00	2.67
tenocyte, donor3	11768-123I4	131.59	4.45	0.00	0.00	0.00	0.37	0.00	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	142.77	11.90	0.17	2.04	0.68	0.51	0.34	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	230.91	11.72	0.62	1.39	0.62	1.23	0.62	1.39
teratocarcinoma cell line:PA-1	10807-111A6	205.19	6.97	0.15	0.46	0.15	0.00	0.15	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	147.89	19.68	0.76	1.40	1.27	2.67	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	158.83	7.19	0.76	0.38	0.38	1.51	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	288.25	6.54	0.11	0.11	0.00	0.87	0.00	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	113.34	11.73	0.33	0.00	0.65	0.65	0.33	4.89
testis, adult, pool1	10026-101D8	77.31	3.11	0.11	1.50	0.97	2.04	0.00	0.43
testis, adult, pool2	10096-102C6	144.35	9.02	0.00	2.71	1.80	4.06	0.90	2.26
thalamus - adult, donor10196	10168-103B6	40.85	3.31	0.00	0.00	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	34.54	2.19	0.00	0.00	0.00	0.16	0.16	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	43.11	6.16	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.95	2.64	0.16	0.00	0.16	0.00	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	48.33	5.75	0.00	0.00	0.00	1.15	0.58	0.00
throat, adult	10209-103G2	70.66	1.25	0.25	0.00	0.00	0.00	0.25	0.25
throat, fetal, donor1	10061-101H7	88.97	1.83	0.00	0.00	0.00	0.00	0.00	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	181.64	11.92	0.60	0.79	0.79	2.98	0.60	0.40
thymus, adult, pool1	10027-101D9	107.87	1.59	0.00	0.00	0.20	0.00	0.10	0.40
thymus, fetal, pool1	10043-101F7	88.21	1.45	0.21	0.10	0.00	0.00	0.00	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	81.64	5.45	0.93	0.00	0.13	0.40	0.13	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	391.55	7.54	1.12	0.84	0.28	1.40	0.42	2.65
thyroid, adult, pool1	10028-101E1	110.48	1.40	0.19	0.00	0.00	0.09	0.00	0.65
thyroid, fetal, donor1	10060-101H6	46.40	1.85	0.00	0.00	0.00	0.00	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	83.15	9.24	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	76.29	0.93	0.23	0.23	0.00	0.23	0.00	1.86
tongue, fetal, donor1	10059-101H5	65.42	1.58	0.00	0.00	0.00	0.00	0.00	2.36
tonsil, adult, pool1	10047-101G2	128.83	2.50	0.00	0.20	0.20	0.30	0.40	0.20
trachea, adult, pool1	10029-101E2	90.55	1.55	0.16	0.16	0.00	0.25	0.00	0.41
trachea, fetal, donor1	10058-101H4	69.63	2.69	0.00	0.00	0.38	0.00	0.00	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	136.40	7.09	0.71	0.35	1.06	0.71	0.35	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	112.06	7.09	2.03	0.20	0.10	0.10	0.71	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	171.89	6.89	0.47	0.16	0.31	0.94	0.31	0.78
tridermal teratoma cell line:HGRT	10694-109G1	249.23	5.71	1.90	0.00	0.00	1.90	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	155.76	3.05	0.51	0.17	0.42	0.25	0.34	1.02
umbilical cord, fetal, donor1	10057-101H3	50.08	2.09	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	224.21	2.22	0.17	0.34	0.17	0.00	0.00	0.51
uterus, fetal, donor1	10055-101H1	92.66	1.54	0.00	0.00	0.00	0.51	0.00	2.05
vagina, adult	10204-103F6	123.42	0.00	0.00	0.00	0.00	0.00	0.00	0.65
vein, adult	10191-103E2	122.75	2.19	0.00	0.00	0.00	0.22	0.00	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	314.57	3.47	1.07	0.00	0.27	0.53	0.27	3.47